Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 498 articles:
HTML format
Text format



Single Articles


    January 2017
  1. CHANNANATH AM, Elkum N, Al-Abdulrazzaq D, Tuomilehto J, et al
    Ethnic differences in association of high body mass index with early onset of Type 1 diabetes - Arab ethnicity as case study.
    PLoS One. 2017;12:e0175728.
    PubMed     Text format     Abstract available


  2. SHARMA S, Zhang Y
    Fourier transform power spectrum is a potential measure of tissue alignment in standard MRI: A multiple sclerosis study.
    PLoS One. 2017;12:e0175979.
    PubMed     Text format     Abstract available


  3. DE MACEDO MSFC, Costa KM, da Silva Filho M
    Voice disorder in systemic lupus erythematosus.
    PLoS One. 2017;12:e0175893.
    PubMed     Text format     Abstract available


  4. ZHANG JJ, Yu GZ, Zheng ZH, Liu YF, et al
    Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy.
    PLoS One. 2017;12:e0175828.
    PubMed     Text format     Abstract available


  5. NAVAS-MADRONAL M, Valero-Mut A, Martinez-Zapata MJ, Simon-Talero MJ, et al
    Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
    PLoS One. 2017;12:e0175538.
    PubMed     Text format     Abstract available


  6. HO TW, Huang CT, Ruan SY, Tsai YJ, et al
    Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.
    PLoS One. 2017;12:e0175794.
    PubMed     Text format     Abstract available


  7. LI JN, Jia X, Wang Y, Xie C, et al
    Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides.
    PLoS One. 2017;12:e0174553.
    PubMed     Text format     Abstract available


  8. HINTSA S, Dube L, Abay M, Angesom T, et al
    Determinants of diabetic nephropathy in Ayder Referral Hospital, Northern Ethiopia: A case-control study.
    PLoS One. 2017;12:e0173566.
    PubMed     Text format     Abstract available


  9. KRAMER J, Tenberge JG, Kleiter I, Gaissmaier W, et al
    Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?
    PLoS One. 2017;12:e0174858.
    PubMed     Text format     Abstract available


  10. ZHANG Y, Wang H, Pan X, Teng W, et al
    Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0175708.
    PubMed     Text format     Abstract available


  11. GUSTAFSSON JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, et al
    Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    PLoS One. 2017;12:e0174572.
    PubMed     Text format     Abstract available


  12. AASS C, Norheim I, Eriksen EF, Bornick EC, et al
    Establishment of a tear protein biomarker panel differentiating between Graves' disease with or without orbitopathy.
    PLoS One. 2017;12:e0175274.
    PubMed     Text format     Abstract available


  13. RAFFEL J, Gafson AR, Dahdaleh S, Malik O, et al
    Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis.
    PLoS One. 2017;12:e0169546.
    PubMed     Text format     Abstract available


  14. ZITTEMA D, Casteleijn NF, Bakker SJ, Boesten LS, et al
    Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.
    PLoS One. 2017;12:e0169263.
    PubMed     Text format     Abstract available


  15. KAVALIUNAS A, Manouchehrinia A, Danylaite Karrenbauer V, Gyllensten H, et al
    Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
    PLoS One. 2017;12:e0169460.
    PubMed     Text format     Abstract available


  16. ATKILT HS, Turago MG, Tegegne BS
    Clinical Characteristics of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in Addis Ababa, Ethiopia: A Cross-Sectional Study.
    PLoS One. 2017;12:e0169666.
    PubMed     Text format     Abstract available


  17. YUAN C, Chu CC, Yan XJ, Bagnara D, et al
    The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    PLoS One. 2017;12:e0167602.
    PubMed     Text format     Abstract available


  18. BONFIGLIO T, Olivero G, Merega E, Di Prisco S, et al
    Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2017;12:e0170825.
    PubMed     Text format     Abstract available


  19. YEUNG KS, Chung BH, Choufani S, Mok MY, et al
    Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway.
    PLoS One. 2017;12:e0169553.
    PubMed     Text format     Abstract available


  20. BYTOFT B, Knorr S, Vlachova Z, Jensen RB, et al
    Assessment of Attention Deficits in Adolescent Offspring Exposed to Maternal Type 1 Diabetes.
    PLoS One. 2017;12:e0169308.
    PubMed     Text format     Abstract available


  21. URRUTIA I, Martinez R, Lopez-Euba T, Velayos T, et al
    Lower Frequency of HLA-DRB1 Type 1 Diabetes Risk Alleles in Pediatric Patients with MODY.
    PLoS One. 2017;12:e0169389.
    PubMed     Text format     Abstract available


  22. HERNANDEZ-MIR G, McGeachy MJ
    CD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis.
    PLoS One. 2017;12:e0173655.
    PubMed     Text format     Abstract available


  23. MISTERSKA E, Kaminiarczyk-Pyzalka D, Adamczak K, Adamczyk KA, et al
    Mental health and adjustment to juvenile idiopathic arthritis: Level of agreement between parent and adolescent reports according to Strengths and Difficulties Questionnaire and Adolescent Outcomes Questionnaire.
    PLoS One. 2017;12:e0173768.
    PubMed     Text format     Abstract available


  24. PAPOTTO PH, Marengo EB, Sardinha LR, Carvalho KI, et al
    Novel CD28 antagonist mPEG PV1-Fab' mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-gamma production.
    PLoS One. 2017;12:e0171822.
    PubMed     Text format     Abstract available


  25. KOMEGAE EN, Souza TA, Grund LZ, Lima C, et al
    Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis.
    PLoS One. 2017;12:e0171796.
    PubMed     Text format     Abstract available


  26. MUNROE ME, Pezant N, Brown MA, Fife DA, et al
    Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis.
    PLoS One. 2017;12:e0171193.
    PubMed     Text format     Abstract available


  27. TOFFOLI B, Gilardi F, Winkler C, Soderberg M, et al
    Nephropathy in Pparg-null mice highlights PPARgamma systemic activities in metabolism and in the immune system.
    PLoS One. 2017;12:e0171474.
    PubMed     Text format     Abstract available


  28. ZOU L, Wang H, Xiao Z, Fang Q, et al
    Tai chi for health benefits in patients with multiple sclerosis: A systematic review.
    PLoS One. 2017;12:e0170212.
    PubMed     Text format     Abstract available


  29. NA W, Yi K, Song YS, Park MH, et al
    Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy.
    PLoS One. 2017;12:e0174501.
    PubMed     Text format     Abstract available


  30. SU YW, Liu PH, Hsu CY, Lee YH, et al
    Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    PLoS One. 2017;12:e0174333.
    PubMed     Text format     Abstract available


  31. LUDVIGSSON J, Jones MP, Faresjo A
    Worm infestations and development of autoimmunity in children - The ABIS study.
    PLoS One. 2017;12:e0173988.
    PubMed     Text format     Abstract available


  32. CECCARELLI F, Sciandrone M, Perricone C, Galvan G, et al
    Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models.
    PLoS One. 2017;12:e0174200.
    PubMed     Text format     Abstract available


  33. ROSENBERGER A, Sohns M, Friedrichs S, Hung RJ, et al
    Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.
    PLoS One. 2017;12:e0173339.
    PubMed     Text format     Abstract available


  34. FAIZY TD, Thaler C, Ceyrowski T, Broocks G, et al
    Reliability of cortical lesion detection on double inversion recovery MRI applying the MAGNIMS-Criteria in multiple sclerosis patients within a 16-months period.
    PLoS One. 2017;12:e0172923.
    PubMed     Text format     Abstract available


  35. MIZUNO M, Noto D, Kaga N, Chiba A, et al
    The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models.
    PLoS One. 2017;12:e0173032.
    PubMed     Text format     Abstract available


  36. BLOSS S, Klemann C, Rother AK, Mehmecke S, et al
    Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey.
    PLoS One. 2017;12:e0172532.
    PubMed     Text format     Abstract available


  37. REGNELL SE, Hessner MJ, Jia S, Akesson L, et al
    Longitudinal analysis of hepatic transcriptome and serum metabolome demonstrates altered lipid metabolism following the onset of hyperglycemia in spontaneously diabetic biobreeding rats.
    PLoS One. 2017;12:e0171372.
    PubMed     Text format     Abstract available


  38. MOON Y, McGinnis RS, Seagers K, Motl RW, et al
    Monitoring gait in multiple sclerosis with novel wearable motion sensors.
    PLoS One. 2017;12:e0171346.
    PubMed     Text format     Abstract available


  39. NICHOLAS D, Proctor EA, Raval FM, Ip BC, et al
    Advances in the quantification of mitochondrial function in primary human immune cells through extracellular flux analysis.
    PLoS One. 2017;12:e0170975.
    PubMed     Text format     Abstract available


  40. LINK J, Ramanujam R, Auer M, Ryner M, et al
    Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.
    PLoS One. 2017;12:e0170395.
    PubMed     Text format     Abstract available


  41. MARTINS CO, Demarchi L, Ferreira FM, Pomerantzeff PM, et al
    Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization.
    PLoS One. 2017;12:e0170191.
    PubMed     Text format     Abstract available


  42. DILLON MP, Fortington LV, Akram M, Erbas B, et al
    Geographic Variation of the Incidence Rate of Lower Limb Amputation in Australia from 2007-12.
    PLoS One. 2017;12:e0170705.
    PubMed     Text format     Abstract available


  43. ETCHEGARAY-MORALES I, Mendez-Martinez S, Jimenez-Hernandez C, Mendoza-Pinto C, et al
    Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol.
    PLoS One. 2017;12:e0170209.
    PubMed     Text format     Abstract available


  44. UECKER FC, Olze H, Kunte H, Gerz C, et al
    Longitudinal Testing of Olfactory and Gustatory Function in Patients with Multiple Sclerosis.
    PLoS One. 2017;12:e0170492.
    PubMed     Text format     Abstract available


  45. HURTADO-GUERRERO I, Pinto-Medel MJ, Urbaneja P, Rodriguez-Bada JL, et al
    Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNss in Multiple Sclerosis Patients According to the Therapeutic Response to IFNss.
    PLoS One. 2017;12:e0170031.
    PubMed     Text format     Abstract available


  46. TIMILSHINA M, Kang Y, Dahal I, You Z, et al
    BJ-3105, a 6-Alkoxypyridin-3-ol Analog, Impairs T Cell Differentiation and Prevents Experimental Autoimmune Encephalomyelitis Disease Progression.
    PLoS One. 2017;12:e0168942.
    PubMed     Text format     Abstract available


  47. ELOI M, Horvath DV, Ortega JC, Prado MS, et al
    25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus Patients.
    PLoS One. 2017;12:e0170323.
    PubMed     Text format     Abstract available


  48. LIBERTINOVA J, Meluzinova E, Tomek A, Horakova D, et al
    Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNbeta.
    PLoS One. 2017;12:e0169957.
    PubMed     Text format     Abstract available


  49. AZZI J, Thueson L, Moore R, Abdoli R, et al
    PI3Kgamma Deficient NOD-Mice Are Protected from Diabetes by Restoring the Balance of Regulatory to Effector-T-Cells.
    PLoS One. 2017;12:e0169695.
    PubMed     Text format     Abstract available


  50. FARIA BF, Mostardinha P, Vistulo de Abreu F
    Can the Immune System Perform a t-Test?
    PLoS One. 2017;12:e0169464.
    PubMed     Text format     Abstract available


  51. ESSIEN O, Otu A, Umoh V, Enang O, et al
    Intensive Patient Education Improves Glycaemic Control in Diabetes Compared to Conventional Education: A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital.
    PLoS One. 2017;12:e0168835.
    PubMed     Text format     Abstract available


  52. BROCHET B, Deloire MS, Perez P, Loock T, et al
    Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.
    PLoS One. 2017;12:e0168834.
    PubMed     Text format     Abstract available


  53. LAND J, Abdulahad WH, Arends S, Sanders JF, et al
    Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis.
    PLoS One. 2017;12:e0182549.
    PubMed     Text format     Abstract available


  54. VAN ESDONK MJ, Tai B, Cotterill A, Charles B, et al
    Prediction of glycaemic control in young children and adolescents with type 1 diabetes mellitus using mixed-effects logistic regression modelling.
    PLoS One. 2017;12:e0182181.
    PubMed     Text format     Abstract available


  55. WAUGH K, Snell-Bergeon J, Michels A, Dong F, et al
    Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY).
    PLoS One. 2017;12:e0174840.
    PubMed     Text format     Abstract available


  56. ZHAO Y, Healy BC, Rotstein D, Guttmann CR, et al
    Exploration of machine learning techniques in predicting multiple sclerosis disease course.
    PLoS One. 2017;12:e0174866.
    PubMed     Text format     Abstract available


  57. KIIRE CA, Horak K, Lee KE, Klein BE, et al
    The period effect in the prevalence of proliferative diabetic retinopathy, gross proteinuria, and peripheral neuropathy in type 1 diabetes: A longitudinal cohort study.
    PLoS One. 2017;12:e0174979.
    PubMed     Text format     Abstract available


  58. HEGEN H, Auer M, Bsteh G, Di Pauli F, et al
    Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.
    PLoS One. 2017;12:e0174005.
    PubMed     Text format     Abstract available


  59. XIA N, Ye X, Hu X, Song S, et al
    Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
    PLoS One. 2017;12:e0174260.
    PubMed     Text format     Abstract available


  60. NICKERSON KM, Wang Y, Bastacky S, Shlomchik MJ, et al
    Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice.
    PLoS One. 2017;12:e0173471.
    PubMed     Text format     Abstract available


  61. LIMA PD, Chen Z, Tayab A, Murphy MS, et al
    Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study.
    PLoS One. 2017;12:e0172988.
    PubMed     Text format     Abstract available


  62. WENDEBOURG MJ, Heesen C, Finlayson M, Meyer B, et al
    Patient education for people with multiple sclerosis-associated fatigue: A systematic review.
    PLoS One. 2017;12:e0173025.
    PubMed     Text format     Abstract available


  63. EUESDEN J, Danese A, Lewis CM, Maughan B, et al
    A bidirectional relationship between depression and the autoimmune disorders - New perspectives from the National Child Development Study.
    PLoS One. 2017;12:e0173015.
    PubMed     Text format     Abstract available


  64. ONO N, Murakami K, Chan O, Hall H, et al
    Exposure to sequestered self-antigens in vivo is not sufficient for the induction of autoimmune diabetes.
    PLoS One. 2017;12:e0173176.
    PubMed     Text format     Abstract available


  65. POURCINE F, Dahan K, Mihout F, Cachanado M, et al
    Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
    PLoS One. 2017;12:e0173201.
    PubMed     Text format     Abstract available


  66. MORANDI E, Tanasescu R, Tarlinton RE, Constantinescu CS, et al
    The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0172415.
    PubMed     Text format     Abstract available


  67. BEHBEHANI R, Abu Al-Hassan A, Al-Salahat A, Sriraman D, et al
    Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
    PLoS One. 2017;12:e0172120.
    PubMed     Text format     Abstract available


  68. VAITAITIS GM, Yussman MG, Waid DM, Wagner DH Jr, et al
    Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
    PLoS One. 2017;12:e0172037.
    PubMed     Text format     Abstract available


  69. HISA K, Yanagimachi MD, Naruto T, Miyamae T, et al
    PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.
    PLoS One. 2017;12:e0171961.
    PubMed     Text format     Abstract available


  70. MOCCIA M, Palladino R, Lanzillo R, Carotenuto A, et al
    Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015.
    PLoS One. 2017;12:e0169489.
    PubMed     Text format     Abstract available


  71. PARK HY, Park JW, Song HJ, Sohn HS, et al
    The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea.
    PLoS One. 2017;12:e0169463.
    PubMed     Text format     Abstract available


  72. MAGNUSSON K, Bech Holte K, Juel NG, Brox JI, et al
    Long term type 1 diabetes is associated with hand pain, disability and stiffness but not with structural hand osteoarthritis features - The Dialong hand study.
    PLoS One. 2017;12:e0177118.
    PubMed     Text format     Abstract available


  73. LAM HV, Nguyen DT, Nguyen CD
    Sibling method increases risk assessment estimates for type 1 diabetes.
    PLoS One. 2017;12:e0176341.
    PubMed     Text format     Abstract available


  74. VAN AALST S, Ludwig IS, van der Zee R, van Eden W, et al
    Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
    PLoS One. 2017;12:e0177365.
    PubMed     Text format     Abstract available


  75. SCOTT A, Chambers D, Goyder E, O'Cathain A, et al
    Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review.
    PLoS One. 2017;12:e0177210.
    PubMed     Text format     Abstract available


  76. LI Q, Ye H, Ding Y, Chen G, et al
    Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.
    PLoS One. 2017;12:e0176064.
    PubMed     Text format     Abstract available


  77. NIEGOWSKA M, Delitala A, Pes GM, Delitala G, et al
    Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults.
    PLoS One. 2017;12:e0176584.
    PubMed     Text format     Abstract available


  78. MARINO KR, Lundberg RL, Jasrotia A, Maranda LS, et al
    A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.
    PLoS One. 2017;12:e0176860.
    PubMed     Text format     Abstract available


  79. IZQUIERDO G, Damas F, Paramo MD, Ruiz-Pena JL, et al
    The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study.
    PLoS One. 2017;12:e0176174.
    PubMed     Text format     Abstract available


  80. XU E, Cao H, Lin L, Liu H, et al
    rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2017;12:e0176471.
    PubMed     Text format     Abstract available


  81. SCHNEIDER R, Bellenberg B, Hoepner R, Kolb EM, et al
    Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    PLoS One. 2017;12:e0176415.
    PubMed     Text format     Abstract available


  82. ZHAN Z, Yang Y, Zhan Y, Chen D, et al
    Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus.
    PLoS One. 2017;12:e0176457.
    PubMed     Text format     Abstract available


  83. INGLESE M, Petracca M, Mormina E, Achiron A, et al
    Cerebellar volume as imaging outcome in progressive multiple sclerosis.
    PLoS One. 2017;12:e0176519.
    PubMed     Text format     Abstract available


  84. QIAO YC, Chen YL, Pan YH, Tian F, et al
    The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0176157.
    PubMed     Text format     Abstract available


  85. TALMAGE GD, Coppes OJM, Javed A, Bernard J, et al
    Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study.
    PLoS One. 2017;12:e0173299.
    PubMed     Text format     Abstract available


  86. HARRIS VK, Bell L, Langan RA, Tuddenham J, et al
    Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response.
    PLoS One. 2017;12:e0175575.
    PubMed     Text format     Abstract available


  87. GIESS RM, Pfuhl C, Behrens JR, Rasche L, et al
    Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    PLoS One. 2017;12:e0175279.
    PubMed     Text format     Abstract available


  88. DOBRAKOWSKI P, Bogocz M, Cholewa K, Rajchel M, et al
    Month of birth and level of insolation as risk factors for multiple sclerosis in Poland.
    PLoS One. 2017;12:e0175156.
    PubMed     Text format     Abstract available


  89. HANAOKA H, Kiyokawa T, Iida H, Ishimori K, et al
    Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.
    PLoS One. 2017;12:e0175152.
    PubMed     Text format     Abstract available


  90. LLAURADO G, Cano A, Hernandez C, Gonzalez-Sastre M, et al
    Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.
    PLoS One. 2017;12:e0174640.
    PubMed     Text format     Abstract available


  91. YAN T, Ke Y, Chen Y, Xu C, et al
    Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.
    PLoS One. 2017;12:e0174735.
    PubMed     Text format     Abstract available


  92. AYUSO T, Aznar P, Soriano L, Olaskoaga A, et al
    Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis.
    PLoS One. 2017;12:e0174726.
    PubMed     Text format     Abstract available


  93. NEEDELL JC, Dinarello CA, Ir D, Robertson CE, et al
    Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.
    PLoS One. 2017;12:e0173968.
    PubMed     Text format     Abstract available


  94. MULS N, Nasr Z, Dang HA, Sindic C, et al
    IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.
    PLoS One. 2017;12:e0173780.
    PubMed     Text format     Abstract available


  95. HIROOKA K, Saito W, Namba K, Mizuuchi K, et al
    Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.
    PLoS One. 2017;12:e0172612.
    PubMed     Text format     Abstract available


  96. ZAPRUTKO T, Kopciuch D, Kus K, Merks P, et al
    Affordability of medicines in the European Union.
    PLoS One. 2017;12:e0172753.
    PubMed     Text format     Abstract available


  97. RAGHAV A, Ahmad J, Alam K
    Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
    PLoS One. 2017;12:e0176970.
    PubMed     Text format     Abstract available


  98. TAKEUCHI Y, Saito A, Ojima Y, Kagaya S, et al
    The influence of the Great East Japan earthquake on microscopic polyangiitis: A retrospective observational study.
    PLoS One. 2017;12:e0177482.
    PubMed     Text format     Abstract available


  99. MOLINA-JIJON E, Rodriguez-Munoz R, Gonzalez-Ramirez R, Namorado-Tonix C, et al
    Aldosterone signaling regulates the over-expression of claudin-4 and -8 at the distal nephron from type 1 diabetic rats.
    PLoS One. 2017;12:e0177362.
    PubMed     Text format     Abstract available


  100. CHARVET LE, Yang J, Shaw MT, Sherman K, et al
    Cognitive function in multiple sclerosis improves with telerehabilitation: Results from a randomized controlled trial.
    PLoS One. 2017;12:e0177177.
    PubMed     Text format     Abstract available


  101. BOUGNERES P, Le Fur S, Valtat S, Kamatani Y, et al
    Using spatio-temporal surveillance data to test the infectious environment of children before type 1 diabetes diagnosis.
    PLoS One. 2017;12:e0170658.
    PubMed     Text format     Abstract available


    January 2016
  102. WANG H, Sha LL, Ma TT, Zhang LX, et al
    Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    PLoS One. 2016;11:e0148197.
    PubMed     Text format     Abstract available


  103. RASCHE L, Heiserich L, Behrens JR, Lenz K, et al
    Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
    PLoS One. 2016;11:e0147968.
    PubMed     Text format     Abstract available


  104. NASH EE, Peters BM, Lilly EA, Noverr MC, et al
    A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.
    PLoS One. 2016;11:e0147969.
    PubMed     Text format     Abstract available


  105. CHENG ST, Chen L, Li SY, Mayoux E, et al
    The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic beta-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.
    PLoS One. 2016;11:e0147391.
    PubMed     Text format     Abstract available


  106. MAEDA Y, Migita K, Higuchi O, Mukaino A, et al
    Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population.
    PLoS One. 2016;11:e0146048.
    PubMed     Text format     Abstract available


  107. SHINTO L, Marracci G, Mohr DC, Bumgarner L, et al
    Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.
    PLoS One. 2016;11:e0147195.
    PubMed     Text format     Abstract available


  108. NIELSEN CH, Bornsen L, Sellebjerg F, Brimnes MK, et al
    Myelin Basic Protein-Induced Production of Tumor Necrosis Factor-alpha and Interleukin-6, and Presentation of the Immunodominant Peptide MBP85-99 by B Cells from Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2016;11:e0146971.
    PubMed     Text format     Abstract available


  109. CHAYKOVSKA L, Heunisch F, von Einem G, Alter ML, et al
    Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography.
    PLoS One. 2016;11:e0145723.
    PubMed     Text format     Abstract available


  110. POPESCU V, Schoonheim MM, Versteeg A, Chaturvedi N, et al
    Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
    PLoS One. 2016;11:e0143942.
    PubMed     Text format     Abstract available


  111. LITTERA R, Chessa L, Onali S, Figorilli F, et al
    Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    PLoS One. 2016;11:e0146086.
    PubMed     Text format     Abstract available


  112. KREMER D, Cui QL, Gottle P, Kuhlmann T, et al
    CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.
    PLoS One. 2016;11:e0146503.
    PubMed     Text format     Abstract available


  113. ZHOU F, Zhuang Y, Gong H, Zhan J, et al
    Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis.
    PLoS One. 2016;11:e0146080.
    PubMed     Text format     Abstract available


  114. KIISKI HS, Ni Riada S, Lalor EC, Goncalves NR, et al
    Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
    PLoS One. 2016;11:e0146084.
    PubMed     Text format     Abstract available


  115. HENNERICI T, Pollmann R, Schmidt T, Seipelt M, et al
    Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus.
    PLoS One. 2016;11:e0148919.
    PubMed     Text format     Abstract available


  116. TSCHOCHNER M, Leary S, Cooper D, Strautins K, et al
    Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    PLoS One. 2016;11:e0147567.
    PubMed     Text format     Abstract available


  117. BONNIER G, Kober T, Schluep M, Du Pasquier R, et al
    A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
    PLoS One. 2016;11:e0148631.
    PubMed     Text format     Abstract available


  118. LIAO Z, Tang H, Xu X, Liang Y, et al
    Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis.
    PLoS One. 2016;11:e0147856.
    PubMed     Text format     Abstract available


  119. WIENDL H, Butzkueven H, Kappos L, Trojano M, et al
    Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).
    PLoS One. 2016;11:e0144834.
    PubMed     Text format     Abstract available


  120. RODIC SZ, Knezevic TI, Kisic-Tepavcevic DB, Dackovic JR, et al
    Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
    PLoS One. 2016;11:e0147042.
    PubMed     Text format     Abstract available


  121. JALILI RB, Zhang Y, Hosseini-Tabatabaei A, Kilani RT, et al
    Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    PLoS One. 2016;11:e0146970.
    PubMed     Text format     Abstract available


  122. RAJAKULENDRAN S, Pitceathly RD, Taanman JW, Costello H, et al
    A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease.
    PLoS One. 2016;11:e0145500.
    PubMed     Text format     Abstract available


  123. RASENACK M, Rychen J, Andelova M, Naegelin Y, et al
    Efficacy and Safety of Fingolimod in an Unselected Patient Population.
    PLoS One. 2016;11:e0146190.
    PubMed     Text format     Abstract available


  124. MURRAY SG, Schmajuk G, Trupin L, Gensler L, et al
    National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia.
    PLoS One. 2016;11:e0144918.
    PubMed     Text format     Abstract available


  125. LIANG D, Zuo A, Zhao R, Shao H, et al
    CD73 Expressed on gammadelta T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis.
    PLoS One. 2016;11:e0150078.
    PubMed     Text format     Abstract available


  126. KLISTORNER A, Wang C, Yiannikas C, Graham SL, et al
    Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
    PLoS One. 2016;11:e0149245.
    PubMed     Text format     Abstract available


  127. LO GULLO A, Koster MJ, Crowson CS, Makol A, et al
    Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.
    PLoS One. 2016;11:e0149579.
    PubMed     Text format     Abstract available


  128. ZAINI WH, Giuliani F, Beaulieu C, Kalra S, et al
    Fatigue in Multiple Sclerosis: Assessing Pontine Involvement Using Proton MR Spectroscopic Imaging.
    PLoS One. 2016;11:e0149622.
    PubMed     Text format     Abstract available


  129. KIM NS, Mbongue JC, Nicholas DA, Esebanmen GE, et al
    Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-kappaB Pathway.
    PLoS One. 2016;11:e0147509.
    PubMed     Text format     Abstract available


  130. TU Y, Wang Y, Ding L, Zhang J, et al
    Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy.
    PLoS One. 2016;11:e0148595.
    PubMed     Text format     Abstract available


  131. MOTTA C, Palermo E, Studer V, Germanotta M, et al
    Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis.
    PLoS One. 2016;11:e0148997.
    PubMed     Text format     Abstract available


  132. VAN LEEUWEN N, Lingsma HF, Vanrolleghem AM, Sturkenboom MC, et al
    Hospital Admissions, Transfers and Costs of Guillain-Barre Syndrome.
    PLoS One. 2016;11:e0143837.
    PubMed     Text format     Abstract available


  133. MARCK CH, Neate SL, Taylor KL, Weiland TJ, et al
    Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.
    PLoS One. 2016;11:e0148573.
    PubMed     Text format     Abstract available


  134. XIA L, Xie H, Yu Y, Zhou H, et al
    The Effects of NF-kappaB and c-Jun/AP-1 on the Expression of Prothrombotic and Proinflammatory Molecules Induced by Anti-beta2GPI in Mouse.
    PLoS One. 2016;11:e0147958.
    PubMed     Text format     Abstract available


  135. D'SOUZA CA, Zhao FL, Li X, Xu Y, et al
    OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.
    PLoS One. 2016;11:e0148439.
    PubMed     Text format     Abstract available


  136. TAM CC, O'Brien SJ
    Economic Cost of Campylobacter, Norovirus and Rotavirus Disease in the United Kingdom.
    PLoS One. 2016;11:e0138526.
    PubMed     Text format     Abstract available


  137. LEE JY, Bae K, Park KA, Lyu IJ, et al
    Correlation between Extraocular Muscle Size Measured by Computed Tomography and the Vertical Angle of Deviation in Thyroid Eye Disease.
    PLoS One. 2016;11:e0148167.
    PubMed     Text format     Abstract available


  138. NARRES M, Claessen H, Droste S, Kvitkina T, et al
    The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.
    PLoS One. 2016;11:e0147329.
    PubMed     Text format     Abstract available


  139. EHRMANN D, Bergis-Jurgan N, Haak T, Kulzer B, et al
    Comparison of the Efficacy of a Diabetes Education Programme for Type 1 Diabetes (PRIMAS) in a Randomised Controlled Trial Setting and the Effectiveness in a Routine Care Setting: Results of a Comparative Effectiveness Study.
    PLoS One. 2016;11:e0147581.
    PubMed     Text format     Abstract available


  140. VAN DER TORREN CR, Verrijn Stuart AA, Lee D, Meerding J, et al
    Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes.
    PLoS One. 2016;11:e0146649.
    PubMed     Text format     Abstract available


  141. AKBAR N, Giorgio A, Till C, Sled JG, et al
    Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.
    PLoS One. 2016;11:e0145906.
    PubMed     Text format     Abstract available


  142. BRANGER P, Parienti JJ, Sormani MP, Defer G, et al
    The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
    PLoS One. 2016;11:e0149685.
    PubMed     Text format     Abstract available


  143. KAMEI K, Harada R, Hamada R, Sakai T, et al
    Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy.
    PLoS One. 2016;11:e0150885.
    PubMed     Text format     Abstract available


  144. RINALDUZZI S, Serafini M, Capozza M, Accornero N, et al
    Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    PLoS One. 2016;11:e0151629.
    PubMed     Text format     Abstract available


  145. TOUPIN APRIL K, Stinson J, Boon H, Duffy CM, et al
    Development and Preliminary Face and Content Validation of the "Which Health Approaches and Treatments Are You Using?" (WHAT) Questionnaires Assessing Complementary and Alternative Medicine Use in Pediatric Rheumatology.
    PLoS One. 2016;11:e0149809.
    PubMed     Text format     Abstract available


  146. PATEL H, Mansuri MS, Singh M, Begum R, et al
    Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism.
    PLoS One. 2016;11:e0149441.
    PubMed     Text format     Abstract available


  147. HELLWIG K, Chen LH, Stancyzk FZ, Langer-Gould AM, et al
    Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility.
    PLoS One. 2016;11:e0149094.
    PubMed     Text format     Abstract available


  148. THORNLEY TB, Agarwal KA, Kyriazis P, Ma L, et al
    Contrasting Roles of Islet Resident Immunoregulatory Macrophages and Dendritic Cells in Experimental Autoimmune Type 1 Diabetes.
    PLoS One. 2016;11:e0150792.
    PubMed     Text format     Abstract available


  149. JURECKA-LUBIENIECKA B, Bednarczuk T, Ploski R, Krajewska J, et al
    Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.
    PLoS One. 2016;11:e0150307.
    PubMed     Text format     Abstract available


  150. KOTHUR K, Wienholt L, Tantsis EM, Earl J, et al
    B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
    PLoS One. 2016;11:e0149411.
    PubMed     Text format     Abstract available


  151. LIN D, Luo X, Meng L, Zhang G, et al
    Optical Intensities of Different Compartments of Subretinal Fluid in Acute Vogt-Koyanagi-Harada Disease.
    PLoS One. 2016;11:e0149376.
    PubMed     Text format     Abstract available


  152. AN H, Lim C, Guillemin GJ, Vollmer-Conna U, et al
    Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
    PLoS One. 2016;11:e0149200.
    PubMed     Text format     Abstract available


  153. LU MC, Chang SC, Huang KY, Koo M, et al
    Higher Risk of Thyroid Disorders in Young Patients with Type 1 Diabetes: A 12-Year Nationwide, Population-Based, Retrospective Cohort Study.
    PLoS One. 2016;11:e0152168.
    PubMed     Text format     Abstract available


  154. PINTER D, Beckmann C, Koini M, Pirker E, et al
    Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
    PLoS One. 2016;11:e0152158.
    PubMed     Text format     Abstract available


  155. HAREL A, Ceccarelli A, Farrell C, Fabian M, et al
    Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
    PLoS One. 2016;11:e0152180.
    PubMed     Text format     Abstract available


  156. OJI S, Nicolussi EM, Kaufmann N, Zeka B, et al
    Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
    PLoS One. 2016;11:e0151244.
    PubMed     Text format     Abstract available


  157. BAGLAENKO Y, Manion KP, Chang NH, Gracey E, et al
    IL-10 Production Is Critical for Sustaining the Expansion of CD5+ B and NKT Cells and Restraining Autoantibody Production in Congenic Lupus-Prone Mice.
    PLoS One. 2016;11:e0150515.
    PubMed     Text format     Abstract available


  158. LOMBARDO M, Parravano M, Serrao S, Ziccardi L, et al
    Investigation of Adaptive Optics Imaging Biomarkers for Detecting Pathological Changes of the Cone Mosaic in Patients with Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0151380.
    PubMed     Text format     Abstract available


  159. PRECHL J, Papp K, Herincs Z, Peterfy H, et al
    Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium.
    PLoS One. 2016;11:e0150685.
    PubMed     Text format     Abstract available


  160. SCHMITT A, Reimer A, Hermanns N, Huber J, et al
    Assessing Diabetes Self-Management with the Diabetes Self-Management Questionnaire (DSMQ) Can Help Analyse Behavioural Problems Related to Reduced Glycaemic Control.
    PLoS One. 2016;11:e0150774.
    PubMed     Text format     Abstract available


  161. LAIMER M, Melmer A, Mader JK, Schutz-Fuhrmann I, et al
    Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0150604.
    PubMed     Text format     Abstract available


  162. ONDA Y, Nishimura R, Morimoto A, Sano H, et al
    Age at Transition from Pediatric to Adult Care Has No Relationship with Mortality for Childhood-Onset Type 1 Diabetes in Japan: Diabetes Epidemiology Research International (DERI) Mortality Study.
    PLoS One. 2016;11:e0150720.
    PubMed     Text format     Abstract available


  163. LEE JY, Paik JS, Yun M, Lee SB, et al
    The Effect of (-)-Epigallocatechin-3-Gallate on IL-1beta Induced IL-8 Expression in Orbital Fibroblast from Patients with Thyroid-Associated Ophthalmopathy.
    PLoS One. 2016;11:e0148645.
    PubMed     Text format     Abstract available


  164. SIMON A, Subra JF, Guilpain P, Jeannin P, et al
    Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
    PLoS One. 2016;11:e0147091.
    PubMed     Text format     Abstract available


  165. WU T, Xie C, Han J, Ye Y, et al
    Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis.
    PLoS One. 2016;11:e0151491.
    PubMed     Text format     Abstract available


  166. FAIZY TD, Thaler C, Kumar D, Sedlacik J, et al
    Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging.
    PLoS One. 2016;11:e0151496.
    PubMed     Text format     Abstract available


  167. CHEVALIER J, Chamoux C, Hammes F, Chicoye A, et al
    Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
    PLoS One. 2016;11:e0150703.
    PubMed     Text format     Abstract available


  168. WU X, Shen D, Li T, Zhang B, et al
    Distinct Clinical Characteristics of Pediatric Guillain-Barre Syndrome: A Comparative Study between Children and Adults in Northeast China.
    PLoS One. 2016;11:e0151611.
    PubMed     Text format     Abstract available


  169. ZHUANG Y, Li Y, Li X, Xie Q, et al
    Atg7 Knockdown Augments Concanavalin A-Induced Acute Hepatitis through an ROS-Mediated p38/MAPK Pathway.
    PLoS One. 2016;11:e0149754.
    PubMed     Text format     Abstract available


  170. PUT K, Brisse E, Avau A, Imbrechts M, et al
    IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    PLoS One. 2016;11:e0150075.
    PubMed     Text format     Abstract available


  171. LIU B, Yue Y, Yang Y, Jin Y, et al
    Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes.
    PLoS One. 2016;11:e0147260.
    PubMed     Text format     Abstract available


  172. RIVERA-LOPEZ R, Jimenez-Jaimez J, Sabio JM, Zamora-Pasadas M, et al
    Relationship between QT Interval Length and Arterial Stiffness in Systemic Lupus Erythematosus (SLE): A Cross-Sectional Case-Control Study.
    PLoS One. 2016;11:e0152291.
    PubMed     Text format     Abstract available


  173. DISANTO G, Benkert P, Lorscheider J, Mueller S, et al
    The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
    PLoS One. 2016;11:e0152347.
    PubMed     Text format     Abstract available


  174. KIM JH, Furrow E, Ritt MG, Utz PJ, et al
    Anti-Insulin Immune Responses Are Detectable in Dogs with Spontaneous Diabetes.
    PLoS One. 2016;11:e0152397.
    PubMed     Text format     Abstract available


  175. SHARMA A, Liu X, Hadley D, Hagopian W, et al
    Identification of Non-HLA Genes Associated with Celiac Disease and Country-Specific Differences in a Large, International Pediatric Cohort.
    PLoS One. 2016;11:e0152476.
    PubMed     Text format     Abstract available


  176. AUDEMARD-VERGER A, Martin Silva N, Verstuyft C, Costedoat-Chalumeau N, et al
    Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide.
    PLoS One. 2016;11:e0151696.
    PubMed     Text format     Abstract available


  177. BARBERA BETANCOURT A, Emery JL, Recino A, Wong FS, et al
    Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production.
    PLoS One. 2016;11:e0146516.
    PubMed     Text format     Abstract available


  178. EL-BADAWY A, El-Badri N
    Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: A Meta-Analysis.
    PLoS One. 2016;11:e0151938.
    PubMed     Text format     Abstract available


  179. DAI R, Lu R, Ahmed SA
    The Upregulation of Genomic Imprinted DLK1-Dio3 miRNAs in Murine Lupus Is Associated with Global DNA Hypomethylation.
    PLoS One. 2016;11:e0153509.
    PubMed     Text format     Abstract available


  180. ARELLANO B, Hussain R, Miller-Little WA, Herndon E, et al
    A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
    PLoS One. 2016;11:e0152720.
    PubMed     Text format     Abstract available


  181. JAIN S, Park G, Sproule TJ, Christianson GJ, et al
    Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB.Yaa Mice.
    PLoS One. 2016;11:e0153059.
    PubMed     Text format     Abstract available


  182. ZABEEN B, Craig ME, Virk SA, Pryke A, et al
    Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality.
    PLoS One. 2016;11:e0153033.
    PubMed     Text format     Abstract available


  183. NAGASAWA Y, Okuzaki D, Muso E, Yamamoto R, et al
    IFI27 Is a Useful Genetic Marker for Diagnosis of Immunoglobulin A Nephropathy and Membranous Nephropathy Using Peripheral Blood.
    PLoS One. 2016;11:e0153252.
    PubMed     Text format     Abstract available


  184. RUGGAJO P, Svarstad E, Leh S, Marti HP, et al
    Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy-A Retrospective Registry-Based Cohort Study.
    PLoS One. 2016;11:e0153819.
    PubMed     Text format     Abstract available


  185. MASSOLT ET, Effraimidis G, Korevaar TI, Wiersinga WM, et al
    Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease.
    PLoS One. 2016;11:e0153892.
    PubMed     Text format     Abstract available


  186. ROSATO R, Testa S, Bertolotto A, Confalonieri P, et al
    Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
    PLoS One. 2016;11:e0153466.
    PubMed     Text format     Abstract available


  187. LIN CH, Hsieh SC, Keng LT, Lee HS, et al
    Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.
    PLoS One. 2016;11:e0153938.
    PubMed     Text format     Abstract available


  188. VEDHARA K, Dawe K, Miles JN, Wetherell MA, et al
    Illness Beliefs Predict Mortality in Patients with Diabetic Foot Ulcers.
    PLoS One. 2016;11:e0153315.
    PubMed     Text format     Abstract available


  189. MURUNGA AN, Miruka DO, Driver C, Nkomo FS, et al
    Grapefruit Derived Flavonoid Naringin Improves Ketoacidosis and Lipid Peroxidation in Type 1 Diabetes Rat Model.
    PLoS One. 2016;11:e0153241.
    PubMed     Text format     Abstract available


  190. SUNDARRAJAN S, Arumugam M
    Comorbidities of Psoriasis - Exploring the Links by Network Approach.
    PLoS One. 2016;11:e0149175.
    PubMed     Text format     Abstract available


  191. KUSPINAR A, Pickard S, Mayo NE
    Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
    PLoS One. 2016;11:e0151905.
    PubMed     Text format     Abstract available


  192. OLSEN JA, Kenna LA, Spelios MG, Hessner MJ, et al
    Circulating Differentially Methylated Amylin DNA as a Biomarker of beta-Cell Loss in Type 1 Diabetes.
    PLoS One. 2016;11:e0152662.
    PubMed     Text format     Abstract available


  193. BARTH S, Haas JP, Schlichtiger J, Molz J, et al
    Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.
    PLoS One. 2016;11:e0153267.
    PubMed     Text format     Abstract available


  194. MARANDA L, Gupta OT
    Association between Responsible Pet Ownership and Glycemic Control in Youths with Type 1 Diabetes.
    PLoS One. 2016;11:e0152332.
    PubMed     Text format     Abstract available


  195. TING WH, Chien MN, Lo FS, Wang CH, et al
    Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
    PLoS One. 2016;11:e0154394.
    PubMed     Text format     Abstract available


  196. BLOCK VA, Pitsch E, Tahir P, Cree BA, et al
    Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
    PLoS One. 2016;11:e0154335.
    PubMed     Text format     Abstract available


  197. MAGGI L, Margheri F, Luciani C, Capone M, et al
    Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients.
    PLoS One. 2016;11:e0154422.
    PubMed     Text format     Abstract available


  198. RAMONDT S, Tiemensma J, Cameron LD, Broadbent E, et al
    Drawings of Blood Cells Reveal People's Perception of Their Blood Disorder: A Pilot Study.
    PLoS One. 2016;11:e0154348.
    PubMed     Text format     Abstract available


  199. AHMED RH, Huri HZ, Al-Hamodi Z, Salem SD, et al
    Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    PLoS One. 2016;11:e0154369.
    PubMed     Text format     Abstract available


  200. HAASNOOT AJ, Vernie LA, Rothova A, V D Doe P, et al
    Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
    PLoS One. 2016;11:e0164312.
    PubMed     Text format     Abstract available


  201. KAUSHIK DK, Yong HY, Hahn JN, Silva C, et al
    Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
    PLoS One. 2016;11:e0163802.
    PubMed     Text format     Abstract available


  202. KALRON A, Givon U, Frid L, Dolev M, et al
    Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis.
    PLoS One. 2016;11:e0164467.
    PubMed     Text format     Abstract available


  203. HAJIEBRAHIMI M, Montgomery S, Burkill S, Bahmanyar S, et al
    Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0165027.
    PubMed     Text format     Abstract available


  204. RIEMANN-LORENZ K, Eilers M, von Geldern G, Schulz KH, et al
    Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.
    PLoS One. 2016;11:e0165246.
    PubMed     Text format     Abstract available


  205. MANICARDI V, Russo G, Napoli A, Torlone E, et al
    Gender-Disparities in Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative.
    PLoS One. 2016;11:e0162960.
    PubMed     Text format     Abstract available


  206. JERNAS L, Wencel J, Wiak A, Bieniek M, et al
    Risk Factors for Poor Adherence to Betaferon(R) Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome.
    PLoS One. 2016;11:e0157950.
    PubMed     Text format     Abstract available


  207. OKANO J, Kojima H, Katagi M, Nakagawa T, et al
    Hyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice.
    PLoS One. 2016;11:e0166215.
    PubMed     Text format     Abstract available


  208. DOBSON R, Ramagopalan S, Topping J, Smith P, et al
    A Risk Score for Predicting Multiple Sclerosis.
    PLoS One. 2016;11:e0164992.
    PubMed     Text format     Abstract available


  209. PROSPERINI L, de Rossi N, Scarpazza C, Moiola L, et al
    Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry.
    PLoS One. 2016;11:e0168376.
    PubMed     Text format     Abstract available


  210. JOHNSON TW, Wu Y, Nathoo N, Rogers JA, et al
    Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0167196.
    PubMed     Text format     Abstract available


  211. VAN DALEM A, Demeester S, Balti EV, Keymeulen B, et al
    Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio.
    PLoS One. 2016;11:e0166702.
    PubMed     Text format     Abstract available


  212. CHATTERJEE S, Bhardwaj N, Saxena RK
    Identification of Stages of Erythroid Differentiation in Bone Marrow and Erythrocyte Subpopulations in Blood Circulation that Are Preferentially Lost in Autoimmune Hemolytic Anemia in Mouse.
    PLoS One. 2016;11:e0166878.
    PubMed     Text format     Abstract available


  213. MARTIN P, McGovern A, Massey J, Schoenfelder S, et al
    Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-C.
    PLoS One. 2016;11:e0166923.
    PubMed     Text format     Abstract available


  214. ZHANG L, Wang L, Tian P, Tian S, et al
    Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
    PLoS One. 2016;11:e0165543.
    PubMed     Text format     Abstract available


  215. RYDEN A, Sorstadius E, Bergenheim K, Romanovschi A, et al
    The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications.
    PLoS One. 2016;11:e0164977.
    PubMed     Text format     Abstract available


  216. KREMER IE, Evers SM, Jongen PJ, van der Weijden T, et al
    Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling.
    PLoS One. 2016;11:e0164862.
    PubMed     Text format     Abstract available


  217. BACHELET D, Hassler S, Mbogning C, Link J, et al
    Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
    PLoS One. 2016;11:e0162752.
    PubMed     Text format     Abstract available


  218. ALROUGHANI R, Akhtar S, Ahmed S, Behbehani R, et al
    Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
    PLoS One. 2016;11:e0165846.
    PubMed     Text format     Abstract available


  219. WANG X, Liu W, O'Donnell M, Lutgendorf S, et al
    Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
    PLoS One. 2016;11:e0168772.
    PubMed     Text format     Abstract available


  220. PIVOT D, Debouverie M, Grzebyk M, Brassat D, et al
    Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.
    PLoS One. 2016;11:e0167556.
    PubMed     Text format     Abstract available


  221. MURIS AH, Smolders J, Rolf L, Klinkenberg LJ, et al
    Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.
    PLoS One. 2016;11:e0156122.
    PubMed     Text format     Abstract available


  222. STAMILE C, Kocevar G, Cotton F, Durand-Dubief F, et al
    A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis.
    PLoS One. 2016;11:e0156405.
    PubMed     Text format     Abstract available


  223. DORONIN VB, Parkhomenko TA, Castellazzi M, Cesnik E, et al
    Comparison of Antibodies with Amylase Activity from Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0154688.
    PubMed     Text format     Abstract available


  224. YASUI J, Kawasaki E, Tanaka S, Awata T, et al
    Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    PLoS One. 2016;11:e0155643.
    PubMed     Text format     Abstract available


  225. CHEN HH, Lin IC, Chen HJ, Yeh SY, et al
    Association of Herpes Zoster and Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0155175.
    PubMed     Text format     Abstract available


  226. LAIBLE M, Jarius S, Mackensen F, Schmidt-Bacher A, et al
    Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0155322.
    PubMed     Text format     Abstract available


  227. BEGGS CB, Magnano C, Belov P, Krawiecki J, et al
    Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0153960.
    PubMed     Text format     Abstract available


  228. YU J, Tian AJ, Yuan X, Cheng XX, et al
    Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
    PLoS One. 2016;11:e0154846.
    PubMed     Text format     Abstract available


  229. LAMPRIANOU S, Gysemans C, Bou Saab J, Pontes H, et al
    Glibenclamide Prevents Diabetes in NOD Mice.
    PLoS One. 2016;11:e0168839.
    PubMed     Text format     Abstract available


  230. SALEHI Z, Doosti R, Beheshti M, Janzamin E, et al
    Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
    PLoS One. 2016;11:e0159565.
    PubMed     Text format     Abstract available


  231. BSTEH G, Ehling R, Lutterotti A, Hegen H, et al
    Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study.
    PLoS One. 2016;11:e0158978.
    PubMed     Text format     Abstract available


  232. VIROSTKO J, Hilmes M, Eitel K, Moore DJ, et al
    Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes.
    PLoS One. 2016;11:e0158825.
    PubMed     Text format     Abstract available


  233. LUIPPOLD G, Bedenik J, Voigt A, Grempler R, et al
    Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations.
    PLoS One. 2016;11:e0156346.
    PubMed     Text format     Abstract available


  234. KARAMYAN A, Dunser MW, Wiebe DJ, Pilz G, et al
    Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.
    PLoS One. 2016;11:e0155795.
    PubMed     Text format     Abstract available


  235. JELINEK GA, De Livera AM, Marck CH, Brown CR, et al
    Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.
    PLoS One. 2016;11:e0161701.
    PubMed     Text format     Abstract available


  236. BINZ N, Rakoczy EP, Ali Rahman IS, Vagaja NN, et al
    Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?
    PLoS One. 2016;11:e0160442.
    PubMed     Text format     Abstract available


  237. ABURAWI EH, AlKaabi J, Zoubeidi T, Shehab A, et al
    Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates.
    PLoS One. 2016;11:e0159808.
    PubMed     Text format     Abstract available


  238. DARABIAN S, Backlund JY, Cleary PA, Sheidaee N, et al
    Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study.
    PLoS One. 2016;11:e0159958.
    PubMed     Text format     Abstract available


  239. DAVIES JL, Thompson S, Kaur-Sandhu H, Sawcer S, et al
    Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis.
    PLoS One. 2016;11:e0158327.
    PubMed     Text format     Abstract available


  240. DENNISON L, McCloy Smith E, Bradbury K, Galea I, et al
    How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study.
    PLoS One. 2016;11:e0158982.
    PubMed     Text format     Abstract available


  241. DAHL LC, Nasa Z, Chung J, Niego B, et al
    The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.
    PLoS One. 2016;11:e0158653.
    PubMed     Text format     Abstract available


  242. ZHAO Z, Zou J, Zhao L, Cheng Y, et al
    Celiac Disease Autoimmunity in Patients with Autoimmune Diabetes and Thyroid Disease among Chinese Population.
    PLoS One. 2016;11:e0157510.
    PubMed     Text format     Abstract available


  243. VALLERIE SN, Kramer F, Barnhart S, Kanter JE, et al
    Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes.
    PLoS One. 2016;11:e0158316.
    PubMed     Text format     Abstract available


  244. SATUE M, Rodrigo MJ, Otin S, Bambo MP, et al
    Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0157293.
    PubMed     Text format     Abstract available


  245. QIN W, Liang YZ, Qin BY, Zhang JL, et al
    The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.
    PLoS One. 2016;11:e0156959.
    PubMed     Text format     Abstract available


  246. D'AMICO E, Leone C, Graziano G, Amato MP, et al
    The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
    PLoS One. 2016;11:e0157721.
    PubMed     Text format     Abstract available


  247. BOUDARHAM J, Hameau S, Zory R, Hardy A, et al
    Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis.
    PLoS One. 2016;11:e0158267.
    PubMed     Text format     Abstract available


  248. PLAISTED WC, Zavala A, Hingco E, Tran H, et al
    Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0157620.
    PubMed     Text format     Abstract available


  249. RIQUELME MEDINA I, Lubovac-Pilav Z
    Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes.
    PLoS One. 2016;11:e0156006.
    PubMed     Text format     Abstract available


  250. BUERTH C, Mausberg AK, Heininger MK, Hartung HP, et al
    Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
    PLoS One. 2016;11:e0155082.
    PubMed     Text format     Abstract available


  251. MASSA MG, Gisevius B, Hirschberg S, Hinz L, et al
    Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
    PLoS One. 2016;11:e0155274.
    PubMed     Text format     Abstract available


  252. MCEWAN P, Bennett H, Fellows J, Priaulx J, et al
    The Health Economic Value of Changes in Glycaemic Control, Weight and Rates of Hypoglycaemia in Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0162441.
    PubMed     Text format     Abstract available


  253. SOLARO C, Trabucco E, Signori A, Martinelli V, et al
    Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
    PLoS One. 2016;11:e0160261.
    PubMed     Text format     Abstract available


  254. SAVASTIO S, Cadario F, Genoni G, Bellomo G, et al
    Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus.
    PLoS One. 2016;11:e0162554.
    PubMed     Text format     Abstract available


  255. YANG Y, Ma YP, Chen DP, Zhuo L, et al
    A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    PLoS One. 2016;11:e0160437.
    PubMed     Text format     Abstract available


  256. BOHN B, Karges B, Vogel C, Otto KP, et al
    20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes.
    PLoS One. 2016;11:e0160971.
    PubMed     Text format     Abstract available


  257. FERNANDEZ O, Arroyo R, Martinez-Yelamos S, Marco M, et al
    Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart(R) Device in Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2016;11:e0160313.
    PubMed     Text format     Abstract available


  258. GRACIEN RM, Jurcoane A, Wagner M, Reitz SC, et al
    The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
    PLoS One. 2016;11:e0161036.
    PubMed     Text format     Abstract available


  259. HASEDA F, Imagawa A, Nishikawa H, Mitsui S, et al
    Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes.
    PLoS One. 2016;11:e0160576.
    PubMed     Text format     Abstract available


  260. IANNETTA M, Zingaropoli MA, Bellizzi A, Morreale M, et al
    Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
    PLoS One. 2016;11:e0160277.
    PubMed     Text format     Abstract available


  261. GILLI F, Chen X, Pachner AR, Gimi B, et al
    High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis.
    PLoS One. 2016;11:e0160071.
    PubMed     Text format     Abstract available


  262. MARTIN JE, Raffel J, Nicholas R
    Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care.
    PLoS One. 2016;11:e0159210.
    PubMed     Text format     Abstract available


  263. DASKALAKI E, Diem P, Mougiakakou SG
    Model-Free Machine Learning in Biomedicine: Feasibility Study in Type 1 Diabetes.
    PLoS One. 2016;11:e0158722.
    PubMed     Text format     Abstract available


  264. ERNSTSSON O, Gyllensten H, Alexanderson K, Tinghog P, et al
    Cost of Illness of Multiple Sclerosis - A Systematic Review.
    PLoS One. 2016;11:e0159129.
    PubMed     Text format     Abstract available


  265. AKAMATSU M, Makino N, Ikeda Y, Matsuda A, et al
    Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    PLoS One. 2016;11:e0158669.
    PubMed     Text format     Abstract available


  266. OBERT D, Helms G, Sattler MB, Jung K, et al
    Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
    PLoS One. 2016;11:e0162583.
    PubMed     Text format     Abstract available


  267. CLAUSEN TD, Bergholt T, Bouaziz O, Arpi M, et al
    Broad-Spectrum Antibiotic Treatment and Subsequent Childhood Type 1 Diabetes: A Nationwide Danish Cohort Study.
    PLoS One. 2016;11:e0161654.
    PubMed     Text format     Abstract available


  268. FATIMA N, Faisal SM, Zubair S, Ajmal M, et al
    Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects.
    PLoS One. 2016;11:e0161548.
    PubMed     Text format     Abstract available


  269. MURAKAMI T, Uji A, Suzuma K, Dodo Y, et al
    In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography.
    PLoS One. 2016;11:e0160317.
    PubMed     Text format     Abstract available


  270. PAOLICELLI D, Iannazzo S, Santoni L, Iaffaldano A, et al
    The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
    PLoS One. 2016;11:e0159214.
    PubMed     Text format     Abstract available


    January 2015
  271. LI J, Xia Y, Liu T, Wang J, et al
    Protective Effects of Astaxanthin on ConA-Induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis.
    PLoS One. 2015;10:e0120440.
    PubMed     Text format     Abstract available


  272. BORNSEN L, Romme Christensen J, Ratzer R, Hedegaard C, et al
    Endogenous Interferon-beta-Inducible Gene Expression and Interferon-beta-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis.
    PLoS One. 2015;10:e0118830.
    PubMed     Text format     Abstract available


  273. DIAZ-VALENCIA PA, Bougneres P, Valleron AJ
    Covariation of the incidence of type 1 diabetes with country characteristics available in public databases.
    PLoS One. 2015;10:e0118298.
    PubMed     Text format     Abstract available


  274. MALHOTRA A, Gundel M, Rajput AM, Mevissen HT, et al
    Knowledge Retrieval from PubMed Abstracts and Electronic Medical Records with the Multiple Sclerosis Ontology.
    PLoS One. 2015;10:e0116718.
    PubMed     Text format     Abstract available


  275. RICIGLIANO VA, Handel AE, Sandve GK, Annibali V, et al
    EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
    PLoS One. 2015;10:e0119605.
    PubMed     Text format     Abstract available


  276. SONODA Y, Gohda T, Suzuki Y, Omote K, et al
    Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.
    PLoS One. 2015;10:e0122212.
    PubMed     Text format     Abstract available


  277. TAMBURO E, Varrica D, Dongarra G, Grimaldi LM, et al
    Trace elements in scalp hair samples from patients with relapsing-remitting multiple sclerosis.
    PLoS One. 2015;10:e0122142.
    PubMed     Text format     Abstract available


  278. MONDAL S, Pahan K
    Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy.
    PLoS One. 2015;10:e0116566.
    PubMed     Text format     Abstract available


  279. SUN Q, Zhang J, Zhou N, Liu X, et al
    DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy.
    PLoS One. 2015;10:e0112305.
    PubMed     Text format     Abstract available


  280. PAN XF, Gu JQ, Shan ZY
    Patients with systemic lupus erythematosus have higher prevalence of thyroid autoantibodies: a systematic review and meta-analysis.
    PLoS One. 2015;10:e0123291.
    PubMed     Text format     Abstract available


  281. HEINZMANN D, Bangert A, Muller AM, von Ungern-Sternberg SN, et al
    The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced Myocarditis.
    PLoS One. 2015;10:e0124606.
    PubMed     Text format     Abstract available


  282. YILMAZ V, Oflazer P, Aysal F, Durmus H, et al
    Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
    PLoS One. 2015;10:e0123546.
    PubMed     Text format     Abstract available


  283. CAO L, Tong H, Xu G, Liu P, et al
    Systemic lupus erythematous and malignancy risk: a meta-analysis.
    PLoS One. 2015;10:e0122964.
    PubMed     Text format     Abstract available


  284. MA TT, Wang H, Wang C, Chang DY, et al
    Urinary levels of high mobility group box-1 are associated with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    PLoS One. 2015;10:e0123586.
    PubMed     Text format     Abstract available


  285. STELLMANN JP, Neuhaus A, Gotze N, Briken S, et al
    Ecological Validity of Walking Capacity Tests in Multiple Sclerosis.
    PLoS One. 2015;10:e0123822.
    PubMed     Text format     Abstract available


  286. MORITA M, Mii A, Shimizu A, Yasuda F, et al
    Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
    PLoS One. 2015;10:e0116700.
    PubMed     Text format     Abstract available


  287. AHMADIAFSHAR A, Mohsenifard MR, Mazloomzadeh S
    Evaluation of Serum & Salivary IgA in Patients with Type 1 Diabetes.
    PLoS One. 2015;10:e0122757.
    PubMed     Text format     Abstract available


  288. TSIVGOULIS G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, et al
    The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
    PLoS One. 2015;10:e0116511.
    PubMed     Text format     Abstract available


  289. SHIELDS SD, Butt RP, Dib-Hajj SD, Waxman SG, et al
    Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis.
    PLoS One. 2015;10:e0119067.
    PubMed     Text format     Abstract available


  290. WU DH, Xu L, Wen CP, Xie GQ, et al
    The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway.
    PLoS One. 2015;10:e0118462.
    PubMed     Text format     Abstract available


  291. MONTI L, Donati D, Menci E, Cioni S, et al
    Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography.
    PLoS One. 2015;10:e0116681.
    PubMed     Text format     Abstract available


  292. BEAROFF F, Case LK, Krementsov DN, Wall EH, et al
    Identification of genetic determinants of the sexual dimorphism in CNS autoimmunity.
    PLoS One. 2015;10:e0117993.
    PubMed     Text format     Abstract available


  293. STELLMANN JP, Sturner KH, Young KL, Siemonsen S, et al
    Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?
    PLoS One. 2015;10:e0116559.
    PubMed     Text format     Abstract available


  294. CHEN H, Zheng D, Ambadapadi S, Davids J, et al
    Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritis.
    PLoS One. 2015;10:e0115482.
    PubMed     Text format     Abstract available


  295. CRAWFORD GL, Boldison J, Copland DA, Adamson P, et al
    The role of lipoprotein-associated phospholipase A2 in a murine model of experimental autoimmune uveoretinitis.
    PLoS One. 2015;10:e0122093.
    PubMed     Text format     Abstract available


  296. YOSSEF R, Gur C, Shemesh A, Guttman O, et al
    Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes.
    PLoS One. 2015;10:e0118936.
    PubMed     Text format     Abstract available


  297. HARMS RZ, Lorenzo KM, Corley KP, Cabrera MS, et al
    Altered CD161bright CD8+ Mucosal Associated Invariant T (MAIT)-Like Cell Dynamics and Increased Differentiation States among Juvenile Type 1 Diabetics.
    PLoS One. 2015;10:e0117335.
    PubMed     Text format     Abstract available


  298. YE X, Zhang L, Wang H, Chen Y, et al
    The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia.
    PLoS One. 2015;10:e0117704.
    PubMed     Text format     Abstract available


  299. AL-RUBEAAN K, Al Derwish M, Ouizi S, Youssef AM, et al
    Diabetic foot complications and their risk factors from a large retrospective cohort study.
    PLoS One. 2015;10:e0124446.
    PubMed     Text format     Abstract available


  300. MOTL RW, Putzki N, Pilutti LA, Cadavid D, et al
    Longitudinal changes in self-reported walking ability in multiple sclerosis.
    PLoS One. 2015;10:e0125002.
    PubMed     Text format     Abstract available


  301. PELISCH N, Dan T, Ichimura A, Sekiguchi H, et al
    Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis.
    PLoS One. 2015;10:e0124510.
    PubMed     Text format     Abstract available


  302. JIA XY, Cui Z, Li JN, Hu SY, et al
    Identification of critical residues of linear B cell epitope on Goodpasture autoantigen.
    PLoS One. 2015;10:e0123277.
    PubMed     Text format     Abstract available


  303. LUYET C, Schulze K, Sayar BS, Howald D, et al
    Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris.
    PLoS One. 2015;10:e0119809.
    PubMed     Text format     Abstract available


  304. BOS SD, Page CM, Andreassen BK, Elboudwarej E, et al
    Genome-Wide DNA Methylation Profiles Indicate CD8+ T Cell Hypermethylation in Multiple Sclerosis.
    PLoS One. 2015;10:e0117403.
    PubMed     Text format     Abstract available


  305. ROMMLER F, Hammel M, Waldhuber A, Muller T, et al
    Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
    PLoS One. 2015;10:e0116703.
    PubMed     Text format     Abstract available


  306. SHANG W, Ning Y, Xu X, Li M, et al
    Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies.
    PLoS One. 2015;10:e0126016.
    PubMed     Text format     Abstract available


  307. GEVAERT T, Moles Lopez X, Sagaert X, Libbrecht L, et al
    Morphometric and quantitative immunohistochemical analysis of disease-related changes in the upper (suburothelial) lamina propria of the human bladder dome.
    PLoS One. 2015;10:e0127020.
    PubMed     Text format     Abstract available


  308. CANDON S, Perez-Arroyo A, Marquet C, Valette F, et al
    Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.
    PLoS One. 2015;10:e0125448.
    PubMed     Text format     Abstract available


  309. PLADYS A, Couchoud C, LeGuillou A, Siebert M, et al
    Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39 811 French dialyzed patients.
    PLoS One. 2015;10:e0125089.
    PubMed     Text format     Abstract available


  310. KONNO S, Suzuki S, Masuda M, Nagane Y, et al
    Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study.
    PLoS One. 2015;10:e0126579.
    PubMed     Text format     Abstract available


  311. CHIUSO-MINICUCCI F, Ishikawa LL, Mimura LA, Fraga-Silva TF, et al
    Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2015;10:e0125836.
    PubMed     Text format     Abstract available


  312. CHEN Z, Lou X, Liu M, Huang D, et al
    Assessment of Optic Nerve Impairment in Patients with Neuromyelitis Optica by MR Diffusion Tensor Imaging.
    PLoS One. 2015;10:e0126574.
    PubMed     Text format     Abstract available


  313. HU C, Huang W, Chen H, Song G, et al
    Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus.
    PLoS One. 2015;10:e0126643.
    PubMed     Text format     Abstract available


  314. WU CC, Huang YS, Chen JS, Huang CF, et al
    Resveratrol ameliorates renal damage, increases expression of heme oxygenase-1, and has anti-complement, anti-oxidative, and anti-apoptotic effects in a murine model of membranous nephropathy.
    PLoS One. 2015;10:e0125726.
    PubMed     Text format     Abstract available


  315. VERINAUD L, Lopes SC, Prado IC, Zanucoli F, et al
    Violacein Treatment Modulates Acute and Chronic Inflammation through the Suppression of Cytokine Production and Induction of Regulatory T Cells.
    PLoS One. 2015;10:e0125409.
    PubMed     Text format     Abstract available


  316. BORTOLIN RH, da Graca Azevedo Abreu BJ, Abbott Galvao Ururahy M, Costa de Souza KS, et al
    Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats.
    PLoS One. 2015;10:e0125349.
    PubMed     Text format     Abstract available


  317. MURPHY SF, Schaeffer AJ, Done J, Wong L, et al
    IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).
    PLoS One. 2015;10:e0125623.
    PubMed     Text format     Abstract available


  318. DU H, Shi L, Chen P, Yang W, et al
    Prohibitin Is Involved in Patients with IgG4 Related Disease.
    PLoS One. 2015;10:e0125331.
    PubMed     Text format     Abstract available


  319. RAKUSA M, Cano SJ, Porter B, Riazi A, et al
    A predictive model for corticosteroid response in individual patients with MS relapses.
    PLoS One. 2015;10:e0120829.
    PubMed     Text format     Abstract available


  320. AYZENBERG I, Schlevogt S, Metzdorf J, Stahlke S, et al
    Analysis of neurogenesis during experimental autoimmune encephalomyelitis reveals pitfalls of bioluminescence imaging.
    PLoS One. 2015;10:e0118550.
    PubMed     Text format     Abstract available


  321. KIM YU, Lim H, Jung HE, Wetsel RA, et al
    Regulation of autoimmune germinal center reactions in lupus-prone BXD2 mice by follicular helper T cells.
    PLoS One. 2015;10:e0120294.
    PubMed     Text format     Abstract available


  322. HIRAKAWA H, Zempo H, Ogawa M, Watanabe R, et al
    A DPP-4 inhibitor suppresses fibrosis and inflammation on experimental autoimmune myocarditis in mice.
    PLoS One. 2015;10:e0119360.
    PubMed     Text format     Abstract available


  323. ZHONG Y, Wang K, Zhang X, Cai X, et al
    Nephrokeli, a Chinese herbal formula, may improve IgA nephropathy through regulation of the sphingosine-1-phosphate pathway.
    PLoS One. 2015;10:e0116873.
    PubMed     Text format     Abstract available


  324. WANG H, Sun L, Tan W
    Clinical features of children with pulmonary microscopic polyangiitis: report of 9 cases.
    PLoS One. 2015;10:e0124352.
    PubMed     Text format     Abstract available


  325. KUEHL MN, Rodriguez H, Burkhardt BR, Alman AC, et al
    Tumor Necrosis Factor-alpha, Matrix-Metalloproteinases 8 and 9 Levels in the Saliva Are Associated with Increased Hemoglobin A1c in Type 1 Diabetes Subjects.
    PLoS One. 2015;10:e0125320.
    PubMed     Text format     Abstract available


  326. BONEPARTH A, Huang W, Bethunaickan R, Woods M, et al
    TLR7 influences germinal center selection in murine SLE.
    PLoS One. 2015;10:e0119925.
    PubMed     Text format     Abstract available


  327. BURKE SD, Seaward AV, Ramshaw H, Smith GN, et al
    Homing Receptor Expression Is Deviated on CD56+ Blood Lymphocytes during Pregnancy in Type 1 Diabetic Women.
    PLoS One. 2015;10:e0119526.
    PubMed     Text format     Abstract available


  328. FAN ZD, Wang FF, Huang H, Huang N, et al
    STAT4 rs7574865 G/T and PTPN22 rs2488457 G/C polymorphisms influence the risk of developing juvenile idiopathic arthritis in Han Chinese patients.
    PLoS One. 2015;10:e0117389.
    PubMed     Text format     Abstract available


  329. BESTER M, Forkert ND, Stellmann JP, Aly L, et al
    Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
    PLoS One. 2015;10:e0119356.
    PubMed     Text format     Abstract available


  330. NAKAJIMA A, Masaki Y, Nakamura T, Kawanami T, et al
    Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.
    PLoS One. 2015;10:e0126582.
    PubMed     Text format     Abstract available


  331. TSYMBALIUK I, Unukovych D, Shvets N, Dinets A, et al
    Cardiovascular complications secondary to Graves' disease: a prospective study from Ukraine.
    PLoS One. 2015;10:e0122388.
    PubMed     Text format     Abstract available


  332. MITCHELL AL, Boe Wolff A, MacArthur K, Weaver JU, et al
    Linkage Analysis in Autoimmune Addison's Disease: NFATC1 as a Potential Novel Susceptibility Locus.
    PLoS One. 2015;10:e0123550.
    PubMed     Text format     Abstract available


  333. TOLLEY K, Hutchinson M, You X, Wang P, et al
    A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2015;10:e0127960.
    PubMed     Text format     Abstract available


  334. HEINE M, van den Akker LE, Verschuren O, Visser-Meily A, et al
    Reliability and Responsiveness of Cardiopulmonary Exercise Testing in Fatigued Persons with Multiple Sclerosis and Low to Mild Disability.
    PLoS One. 2015;10:e0122260.
    PubMed     Text format     Abstract available


  335. HSIN YC, Zhuang LZ, Yeh KW, Chang CW, et al
    Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan.
    PLoS One. 2015;10:e0128768.
    PubMed     Text format     Abstract available


  336. JARAZO DIETRICH S, Fass MI, Jacobo PV, Sobarzo CM, et al
    Inhibition of NOS-NO System Prevents Autoimmune Orchitis Development in Rats: Relevance of NO Released by Testicular Macrophages in Germ Cell Apoptosis and Testosterone Secretion.
    PLoS One. 2015;10:e0128709.
    PubMed     Text format     Abstract available


  337. LIU Y, Ye J, Shin Ogawa L, Inoue T, et al
    The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.
    PLoS One. 2015;10:e0127361.
    PubMed     Text format     Abstract available


  338. HARRIS TL, McGargill MA
    Drak2 Does Not Regulate TGF-beta Signaling in T Cells.
    PLoS One. 2015;10:e0123650.
    PubMed     Text format     Abstract available


  339. ZHAO Y, Zhu L, Zhou T, Zhang Q, et al
    Urinary CXCL1: a novel predictor of IgA nephropathy progression.
    PLoS One. 2015;10:e0119033.
    PubMed     Text format     Abstract available


  340. RAMBERGER M, Peschl P, Schanda K, Irschick R, et al
    Comparison of diagnostic accuracy of microscopy and flow cytometry in evaluating N-methyl-D-aspartate receptor antibodies in serum using a live cell-based assay.
    PLoS One. 2015;10:e0122037.
    PubMed     Text format     Abstract available


  341. HAYASHI T, Yao S, Crain B, Promessi VJ, et al
    Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes.
    PLoS One. 2015;10:e0129867.
    PubMed     Text format     Abstract available


  342. ALLAN ER, Yates RM
    Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2015;10:e0128945.
    PubMed     Text format     Abstract available


  343. SOLTI I, Kvell K, Talaber G, Veto S, et al
    Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis.
    PLoS One. 2015;10:e0129217.
    PubMed     Text format     Abstract available


  344. RIBBONS KA, McElduff P, Boz C, Trojano M, et al
    Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
    PLoS One. 2015;10:e0122686.
    PubMed     Text format     Abstract available


  345. BATES MA, Brandenberger C, Langohr I, Kumagai K, et al
    Silica Triggers Inflammation and Ectopic Lymphoid Neogenesis in the Lungs in Parallel with Accelerated Onset of Systemic Autoimmunity and Glomerulonephritis in the Lupus-Prone NZBWF1 Mouse.
    PLoS One. 2015;10:e0125481.
    PubMed     Text format     Abstract available


  346. DEJACO C, Oppl B, Monach P, Cuthbertson D, et al
    Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    PLoS One. 2015;10:e0121737.
    PubMed     Text format     Abstract available


  347. SHIMIZU F, Nishihara H, Sano Y, Takeshita Y, et al
    Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.
    PLoS One. 2015;10:e0122000.
    PubMed     Text format     Abstract available


  348. KLISTORNER A, Vootakuru N, Wang C, Yiannikas C, et al
    Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter.
    PLoS One. 2015;10:e0122114.
    PubMed     Text format     Abstract available



  349. Correction: direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients.
    PLoS One. 2015;10:e0120947.
    PubMed     Text format    


  350. LALWANI P, de Souza GK, de Lima DS, Passos LF, et al
    Serum thiols as a biomarker of disease activity in lupus nephritis.
    PLoS One. 2015;10:e0119947.
    PubMed     Text format     Abstract available


  351. DEL PICCOLO L, Pietrolongo E, Radice D, Tortorella C, et al
    Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
    PLoS One. 2015;10:e0127734.
    PubMed     Text format     Abstract available


  352. CRUZ Y, Lorea J, Mestre H, Kim-Lee JH, et al
    Copolymer-1 promotes neurogenesis and improves functional recovery after acute ischemic stroke in rats.
    PLoS One. 2015;10:e0121854.
    PubMed     Text format     Abstract available


  353. PATTI F, De Stefano M, Lavorgna L, Messina S, et al
    Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
    PLoS One. 2015;10:e0120754.
    PubMed     Text format     Abstract available


  354. HAWRO T, Bogucki A, Krupinska-Kun M, Maurer M, et al
    Intractable Headaches, Ischemic Stroke, and Seizures Are Linked to the Presence of Anti-beta2GPI Antibodies in Patients with Systemic Lupus Erythematosus.
    PLoS One. 2015;10:e0119911.
    PubMed     Text format     Abstract available


  355. MATTIOLI F, Stampatori C, Bellomi F, Scarpazza C, et al
    Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.
    PLoS One. 2015;10:e0131803.
    PubMed     Text format     Abstract available


  356. MENG Q, Xin L, Liu W, Lin H, et al
    Diagnosis and Treatment of Autoimmune Pancreatitis in China: A Systematic Review.
    PLoS One. 2015;10:e0130466.
    PubMed     Text format     Abstract available


  357. ANDREASSEN OA, Desikan RS, Wang Y, Thompson WK, et al
    Abundant genetic overlap between blood lipids and immune-mediated diseases indicates shared molecular genetic mechanisms.
    PLoS One. 2015;10:e0123057.
    PubMed     Text format     Abstract available


  358. PETROPOULOS IN, Green P, Chan AW, Alam U, et al
    Corneal Confocal Microscopy Detects Neuropathy in Patients with Type 1 Diabetes without Retinopathy or Microalbuminuria.
    PLoS One. 2015;10:e0123517.
    PubMed     Text format     Abstract available


  359. LIAO X, Ren J, Wei CH, Ross AC, et al
    Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
    PLoS One. 2015;10:e0118176.
    PubMed     Text format     Abstract available


  360. ALLIZOND V, Scutera S, Rossi S, Musso T, et al
    Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data.
    PLoS One. 2015;10:e0131557.
    PubMed     Text format     Abstract available


  361. FINDLING O, Baltisberger M, Jung S, Kamm CP, et al
    Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
    PLoS One. 2015;10:e0121856.
    PubMed     Text format     Abstract available


  362. ZHORNITSKY S, Greenfield J, Koch MW, Patten SB, et al
    Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.
    PLoS One. 2015;10:e0123824.
    PubMed     Text format     Abstract available


  363. VESTERINEN HM, Connick P, Irvine CM, Sena ES, et al
    Drug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosis.
    PLoS One. 2015;10:e0117705.
    PubMed     Text format     Abstract available


  364. AEINEHBAND S, Lindblom RP, Al Nimer F, Vijayaraghavan S, et al
    Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
    PLoS One. 2015;10:e0122048.
    PubMed     Text format     Abstract available


  365. SIMPFENDORFER KR, Strugnell RA, Brodnicki TC, Wijburg OL, et al
    Increased Autoimmune Diabetes in pIgR-Deficient NOD Mice Is Due to a "Hitchhiking" Interval that Refines the Genetic Effect of Idd5.4.
    PLoS One. 2015;10:e0121979.
    PubMed     Text format     Abstract available


  366. BACHLE C, Lange K, Stahl-Pehe A, Castillo K, et al
    Symptoms of Eating Disorders and Depression in Emerging Adults with Early-Onset, Long-Duration Type 1 Diabetes and Their Association with Metabolic Control.
    PLoS One. 2015;10:e0131027.
    PubMed     Text format     Abstract available


  367. MANCUSO R, Hernis A, Agostini S, Rovaris M, et al
    Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis.
    PLoS One. 2015;10:e0130715.
    PubMed     Text format     Abstract available


  368. RONDA MC, Dijkhorst-Oei LT, Rutten GE
    Patients' Experiences with and Attitudes towards a Diabetes Patient Web Portal.
    PLoS One. 2015;10:e0129403.
    PubMed     Text format     Abstract available


  369. PERGA S, Giuliano Albo A, Lis K, Minari N, et al
    Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.
    PLoS One. 2015;10:e0129291.
    PubMed     Text format     Abstract available


  370. JACOBSEN R, Hypponen E, Sorensen TI, Vaag AA, et al
    Gestational and Early Infancy Exposure to Margarine Fortified with Vitamin D through a National Danish Programme and the Risk of Type 1 Diabetes: The D-Tect Study.
    PLoS One. 2015;10:e0128631.
    PubMed     Text format     Abstract available


  371. NATHOO N, Rogers JA, Yong VW, Dunn JF, et al
    Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
    PLoS One. 2015;10:e0127033.
    PubMed     Text format     Abstract available


  372. NAGHAVIAN R, Ghaedi K, Kiani-Esfahani A, Ganjalikhani-Hakemi M, et al
    miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.
    PLoS One. 2015;10:e0124555.
    PubMed     Text format     Abstract available


  373. FRANCESCATO MP, Stel G, Stenner E, Geat M, et al
    Prolonged exercise in type 1 diabetes: performance of a customizable algorithm to estimate the carbohydrate supplements to minimize glycemic imbalances.
    PLoS One. 2015;10:e0125220.
    PubMed     Text format     Abstract available


  374. STILUND M, Gjelstrup MC, Petersen T, Moller HJ, et al
    Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
    PLoS One. 2015;10:e0119681.
    PubMed     Text format     Abstract available


  375. LERAY E, Vukusic S, Debouverie M, Clanet M, et al
    Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
    PLoS One. 2015;10:e0132033.
    PubMed     Text format     Abstract available


  376. WANG N, Rajasekaran N, Hou T, Macaubas C, et al
    Immunological Basis for Rapid Progression of Diabetes in Older NOD Mouse Recipients Post BM-HSC Transplantation.
    PLoS One. 2015;10:e0128494.
    PubMed     Text format     Abstract available


  377. KAUR K, Zheng NY, Smith K, Huang M, et al
    High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination.
    PLoS One. 2015;10:e0125618.
    PubMed     Text format     Abstract available


  378. BADR G, Sayed A, Abdel-Maksoud MA, Mohamed AO, et al
    Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NFkappaB and ERK.
    PLoS One. 2015;10:e0125340.
    PubMed     Text format     Abstract available


  379. MALLI C, Pandit L, D'Cunha A, Mustafa S, et al
    Environmental factors related to multiple sclerosis in Indian population.
    PLoS One. 2015;10:e0124064.
    PubMed     Text format     Abstract available


  380. BENCHIMOL EI, Manuel DG, To T, Mack DR, et al
    Asthma, Type 1 and Type 2 Diabetes Mellitus, and Inflammatory Bowel Disease amongst South Asian Immigrants to Canada and Their Children: A Population-Based Cohort Study.
    PLoS One. 2015;10:e0123599.
    PubMed     Text format     Abstract available


  381. BOZIN I, Ge Y, Kuchling J, Dusek P, et al
    Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.
    PLoS One. 2015;10:e0128386.
    PubMed     Text format     Abstract available


  382. BENDAS A, Rothe U, Kiess W, Kapellen TM, et al
    Trends in Incidence Rates during 1999-2008 and Prevalence in 2008 of Childhood Type 1 Diabetes Mellitus in GERMANY - Model-Based National Estimates.
    PLoS One. 2015;10:e0132716.
    PubMed     Text format     Abstract available


  383. AKKAD DA, Olischewsky A, Reiner F, Hellwig K, et al
    Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity.
    PLoS One. 2015;10:e0127632.
    PubMed     Text format     Abstract available


  384. FAVARETTO A, Poggiali D, Lazzarotto A, Rolma G, et al
    The Parallel Analysis of Phase Sensitive Inversion Recovery (PSIR) and Double Inversion Recovery (DIR) Images Significantly Improves the Detection of Cortical Lesions in Multiple Sclerosis (MS) since Clinical Onset.
    PLoS One. 2015;10:e0127805.
    PubMed     Text format     Abstract available


  385. OGUCHI T, Ota M, Ito T, Hamano H, et al
    Investigation of susceptibility genes triggering lachrymal/salivary gland lesion complications in Japanese patients with type 1 autoimmune pancreatitis.
    PLoS One. 2015;10:e0127078.
    PubMed     Text format     Abstract available


  386. YANG C, Fei Y, Qin Y, Luo D, et al
    Bacterial Flora Changes in Conjunctiva of Rats with Streptozotocin-Induced Type I Diabetes.
    PLoS One. 2015;10:e0133021.
    PubMed     Text format     Abstract available


  387. DOMINGUETI CP, Dusse LM, Foscolo RB, Reis JS, et al
    Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
    PLoS One. 2015;10:e0132784.
    PubMed     Text format     Abstract available


  388. ZHUANG Y, Zhou F, Gong H
    Intrinsic Functional Plasticity of the Sensorimotor Network in Relapsing-Remitting Multiple Sclerosis: Evidence from a Centrality Analysis.
    PLoS One. 2015;10:e0130524.
    PubMed     Text format     Abstract available


  389. VAN DER HIELE K, van Gorp D, Ruimschotel R, Kamminga N, et al
    Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2015;10:e0129228.
    PubMed     Text format     Abstract available


  390. SHIELDS EJ, Lam CJ, Cox AR, Rankin MM, et al
    Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes.
    PLoS One. 2015;10:e0129809.
    PubMed     Text format     Abstract available


  391. TEJERA-ALHAMBRA M, Casrouge A, de Andres C, Seyfferth A, et al
    Plasma biomarkers discriminate clinical forms of multiple sclerosis.
    PLoS One. 2015;10:e0128952.
    PubMed     Text format     Abstract available


  392. HYUN JW, Kim SH, Jeong IH, Ahn SW, et al
    Utility of the rio score and modified rio score in korean patients with multiple sclerosis.
    PLoS One. 2015;10:e0129243.
    PubMed     Text format     Abstract available


  393. KORNETE M, Mason ES, Girouard J, Lafferty EI, et al
    Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to beta-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    PLoS One. 2015;10:e0126311.
    PubMed     Text format     Abstract available


  394. AVSAR T, Durasi IM, Uygunoglu U, Tutuncu M, et al
    CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes.
    PLoS One. 2015;10:e0122045.
    PubMed     Text format     Abstract available


  395. EHLER J, Koball S, Sauer M, Mitzner S, et al
    Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
    PLoS One. 2015;10:e0134583.
    PubMed     Text format     Abstract available


  396. FAN X, Jin T, Zhao S, Liu C, et al
    Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.
    PLoS One. 2015;10:e0134523.
    PubMed     Text format     Abstract available


  397. HAUROGNE K, Pavlovic M, Rogniaux H, Bach JM, et al
    Type 1 Diabetes Prone NOD Mice Have Diminished Cxcr1 mRNA Expression in Polymorphonuclear Neutrophils and CD4+ T Lymphocytes.
    PLoS One. 2015;10:e0134365.
    PubMed     Text format     Abstract available


  398. HANSEN K, Schussel K, Kieble M, Werning J, et al
    Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
    PLoS One. 2015;10:e0133279.
    PubMed     Text format     Abstract available


  399. SEVERIJNS D, Octavia JR, Kerkhofs L, Coninx K, et al
    Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis.
    PLoS One. 2015;10:e0133729.
    PubMed     Text format     Abstract available


  400. ANDERSSON DP, Ekstrom U, Lehtihet M
    Rigiscan Evaluation of Men with Diabetes Mellitus and Erectile Dysfunction and Correlation with Diabetes Duration, Age, BMI, Lipids and HbA1c.
    PLoS One. 2015;10:e0133121.
    PubMed     Text format     Abstract available


  401. AL-SHAMMRI SN, Hanna MG, Chattopadhyay A, Akanji AO, et al
    Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
    PLoS One. 2015;10:e0132106.
    PubMed     Text format     Abstract available


  402. PUJOL-AUTONELL I, Serracant-Prat A, Cano-Sarabia M, Ampudia RM, et al
    Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes.
    PLoS One. 2015;10:e0127057.
    PubMed     Text format     Abstract available


  403. BRUGNARA L, Mallol R, Ribalta J, Vinaixa M, et al
    Improving Assessment of Lipoprotein Profile in Type 1 Diabetes by 1H NMR Spectroscopy.
    PLoS One. 2015;10:e0136348.
    PubMed     Text format     Abstract available


  404. MOSER O, Tschakert G, Mueller A, Groeschl W, et al
    Effects of High-Intensity Interval Exercise versus Moderate Continuous Exercise on Glucose Homeostasis and Hormone Response in Patients with Type 1 Diabetes Mellitus Using Novel Ultra-Long-Acting Insulin.
    PLoS One. 2015;10:e0136489.
    PubMed     Text format     Abstract available


  405. BURCH TC, Morris MA, Campbell-Thompson M, Pugliese A, et al
    Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes.
    PLoS One. 2015;10:e0135663.
    PubMed     Text format     Abstract available


  406. SCHEUING N, Wiegand S, Bachle C, Frohlich-Reiterer E, et al
    Impact of Maternal Country of Birth on Type-1-Diabetes Therapy and Outcome in 27,643 Children and Adolescents from the DPV Registry.
    PLoS One. 2015;10:e0135178.
    PubMed     Text format     Abstract available


  407. BERTOLI D, Serana F, Sottini A, Cordioli C, et al
    Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene.
    PLoS One. 2015;10:e0135441.
    PubMed     Text format     Abstract available


  408. NYGAARD GO, Celius EG, de Rodez Benavent SA, Sowa P, et al
    A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity.
    PLoS One. 2015;10:e0135974.
    PubMed     Text format     Abstract available


  409. ORTIZ MA, Nunez C, Ordonez D, Alvarez-Cermeno JC, et al
    Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.
    PLoS One. 2015;10:e0134414.
    PubMed     Text format     Abstract available


  410. GENNARO G, Claudino M, Cestari TM, Ceolin D, et al
    Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats.
    PLoS One. 2015;10:e0134784.
    PubMed     Text format     Abstract available


  411. CALABRESE M, Reynolds R, Magliozzi R, Castellaro M, et al
    Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
    PLoS One. 2015;10:e0135428.
    PubMed     Text format     Abstract available


  412. MADDALONI E, Lessan N, Al Tikriti A, Buzzetti R, et al
    Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement.
    PLoS One. 2015;10:e0131837.
    PubMed     Text format     Abstract available


  413. MALYAVANTHAM K, Weinstock-Guttman B, Suresh L, Zivadinov R, et al
    Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
    PLoS One. 2015;10:e0129503.
    PubMed     Text format     Abstract available


  414. VENKATARAMAN K, Tan LS, Bautista DC, Griva K, et al
    Psychometric Properties of the Problem Areas in Diabetes (PAID) Instrument in Singapore.
    PLoS One. 2015;10:e0136759.
    PubMed     Text format     Abstract available


  415. SUGIMOTO M, Takagi T, Suzuki R, Konno N, et al
    Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study.
    PLoS One. 2015;10:e0138604.
    PubMed     Text format     Abstract available


  416. MATTHEWS L, Kolind S, Brazier A, Leite MI, et al
    Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.
    PLoS One. 2015;10:e0137715.
    PubMed     Text format     Abstract available


  417. IONESCU-TIRGOVISTE C, Gagniuc PA, Guja C
    Structural Properties of Gene Promoters Highlight More than Two Phenotypes of Diabetes.
    PLoS One. 2015;10:e0137950.
    PubMed     Text format     Abstract available


  418. MAZZARA S, Sinisi A, Cardaci A, Rossi RL, et al
    Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis.
    PLoS One. 2015;10:e0137927.
    PubMed     Text format     Abstract available


  419. BISCHOF J, Muller S, Borufka L, Asghari F, et al
    Quantitative Trait Locus Analysis Implicates CD4+/CD44high Memory T Cells in the Pathogenesis of Murine Autoimmune Pancreatitis.
    PLoS One. 2015;10:e0136298.
    PubMed     Text format     Abstract available


  420. LEE AC, Lam JK, Shiu SW, Wong Y, et al
    Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes.
    PLoS One. 2015;10:e0137330.
    PubMed     Text format     Abstract available


  421. MOUZAKI A, Rodi M, Dimisianos N, Emmanuil A, et al
    Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    PLoS One. 2015;10:e0135434.
    PubMed     Text format     Abstract available


  422. GAUTIER JF, Porcher R, Abi Khalil C, Bellili-Munoz N, et al
    Kidney Dysfunction in Adult Offspring Exposed In Utero to Type 1 Diabetes Is Associated with Alterations in Genome-Wide DNA Methylation.
    PLoS One. 2015;10:e0134654.
    PubMed     Text format     Abstract available


  423. LEIKFOSS IS, Keshari PK, Gustavsen MW, Bjolgerud A, et al
    Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
    PLoS One. 2015;10:e0132957.
    PubMed     Text format     Abstract available


  424. CHOI JH, Lee MJ, Jang M, Kim EJ, et al
    An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
    PLoS One. 2015;10:e0138592.
    PubMed     Text format     Abstract available


  425. WENS I, Dalgas U, Vandenabeele F, Grevendonk L, et al
    High Intensity Exercise in Multiple Sclerosis: Effects on Muscle Contractile Characteristics and Exercise Capacity, a Randomised Controlled Trial.
    PLoS One. 2015;10:e0133697.
    PubMed     Text format     Abstract available


  426. ZIEMSSEN T, Rauer S, Stadelmann C, Henze T, et al
    Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.
    PLoS One. 2015;10:e0138243.
    PubMed     Text format     Abstract available


  427. JONKMAN LE, Rosenthal DM, Sormani MP, Miles L, et al
    Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.
    PLoS One. 2015;10:e0129380.
    PubMed     Text format     Abstract available


  428. CARVALHO-SANTOS A, Ribeiro-Alves M, Cardoso-Weide LC, Nunes J, et al
    Decreased Circulating Levels of APRIL: Questioning Its Role in Diabetes.
    PLoS One. 2015;10:e0140150.
    PubMed     Text format     Abstract available


  429. RYNINKS K, Sutton E, Thomas E, Jago R, et al
    Attitudes to Exercise and Diabetes in Young People with Type 1 Diabetes Mellitus: A Qualitative Analysis.
    PLoS One. 2015;10:e0137562.
    PubMed     Text format     Abstract available


  430. LLAURADO G, Megia A, Cano A, Gimenez-Palop O, et al
    FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness.
    PLoS One. 2015;10:e0140222.
    PubMed     Text format     Abstract available


  431. ABRAHAM A, Alabdali M, Qrimli M, Albulaihe H, et al
    Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
    PLoS One. 2015;10:e0139674.
    PubMed     Text format     Abstract available


  432. NIELSEN HH, Beck HC, Kristensen LP, Burton M, et al
    The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
    PLoS One. 2015;10:e0139659.
    PubMed     Text format     Abstract available


  433. HEESEN C, Kasper J, Fischer K, Kopke S, et al
    Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions.
    PLoS One. 2015;10:e0138364.
    PubMed     Text format     Abstract available


  434. CHEN M, Tian X, Qin F, Zhou J, et al
    Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death.
    PLoS One. 2015;10:e0139144.
    PubMed     Text format     Abstract available


  435. ARAVINDHAN V, Mohan V, Arunkumar N, Sandhya S, et al
    Chronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications.
    PLoS One. 2015;10:e0137618.
    PubMed     Text format     Abstract available


  436. NWOSU BU, Maranda L, Cullen K, Greenman L, et al
    A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.
    PLoS One. 2015;10:e0137525.
    PubMed     Text format     Abstract available


  437. LOPEZ-GONGORA M, Escartin A, Martinez-Horta S, Fernandez-Bobadilla R, et al
    Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
    PLoS One. 2015;10:e0136786.
    PubMed     Text format     Abstract available


  438. LAMARGUE HAMEL D, Deloire M, Ruet A, Charre-Morin J, et al
    Deciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life.
    PLoS One. 2015;10:e0142152.
    PubMed     Text format     Abstract available


  439. PERKINS BA, Cherney DZ, Soleymanlou N, Lee JA, et al
    Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes.
    PLoS One. 2015;10:e0141085.
    PubMed     Text format     Abstract available


  440. AL-TEMAIMI RA, Al-Enezi A, Al-Serri A, Al-Roughani R, et al
    The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait.
    PLoS One. 2015;10:e0142265.
    PubMed     Text format     Abstract available


  441. OSTROVSKI I, Lovblom LE, Farooqi MA, Scarr D, et al
    Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor Polyneuropathy.
    PLoS One. 2015;10:e0142309.
    PubMed     Text format     Abstract available


  442. WISTING L, Bang L, Skrivarhaug T, Dahl-Jorgensen K, et al
    Adolescents with Type 1 Diabetes - The Impact of Gender, Age, and Health-Related Functioning on Eating Disorder Psychopathology.
    PLoS One. 2015;10:e0141386.
    PubMed     Text format     Abstract available


  443. SELVARAJAH D, Cash T, Davies J, Sankar A, et al
    SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy.
    PLoS One. 2015;10:e0138224.
    PubMed     Text format     Abstract available


  444. ELEK Z, Nemeth N, Nagy G, Nemeth H, et al
    Micro-RNA Binding Site Polymorphisms in the WFS1 Gene Are Risk Factors of Diabetes Mellitus.
    PLoS One. 2015;10:e0139519.
    PubMed     Text format     Abstract available


  445. THALER C, Faizy T, Sedlacik J, Holst B, et al
    T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
    PLoS One. 2015;10:e0144693.
    PubMed     Text format     Abstract available


  446. MITSUISHI S, Nishimura R, Ando K, Tsujino D, et al
    Can Fasting Glucose Levels or Post-Breakfast Glucose Fluctuations Predict the Occurrence of Nocturnal Asymptomatic Hypoglycemia in Type 1 Diabetic Patients Receiving Basal-Bolus Insulin Therapy with Long-Acting Insulin?
    PLoS One. 2015;10:e0144041.
    PubMed     Text format     Abstract available


  447. HANSEN L, Schmidt-Christensen A, Gupta S, Fransen-Pettersson N, et al
    E2-2 Dependent Plasmacytoid Dendritic Cells Control Autoimmune Diabetes.
    PLoS One. 2015;10:e0144090.
    PubMed     Text format     Abstract available


  448. ASSAYAG-ASHERIE N, Sever D, Bogdani M, Johnson P, et al
    Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes.
    PLoS One. 2015;10:e0143589.
    PubMed     Text format     Abstract available


  449. KANNEL K, Alnek K, Vahter L, Gross-Paju K, et al
    Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment Outcome.
    PLoS One. 2015;10:e0143393.
    PubMed     Text format     Abstract available


  450. VAN NOORT JM, Bsibsi M, Nacken PJ, Verbeek R, et al
    Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.
    PLoS One. 2015;10:e0143366.
    PubMed     Text format     Abstract available


  451. AN HAACK I, Derkow K, Riehn M, Rentinck MN, et al
    The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis.
    PLoS One. 2015;10:e0143715.
    PubMed     Text format     Abstract available


  452. GAGLIANI N, Jofra T, Posgai AL, Atkinson MA, et al
    Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice.
    PLoS One. 2015;10:e0142318.
    PubMed     Text format     Abstract available


  453. MIGITA K, Komori A, Kozuru H, Jiuchi Y, et al
    Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.
    PLoS One. 2015;10:e0136908.
    PubMed     Text format     Abstract available


  454. VALERA P, Zavattari P, Sanna A, Pretti S, et al
    Zinc and Other Metals Deficiencies and Risk of Type 1 Diabetes: An Ecological Study in the High Risk Sardinia Island.
    PLoS One. 2015;10:e0141262.
    PubMed     Text format     Abstract available


  455. ALONSO N, Julian MT, Carrascal J, Colobran R, et al
    Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8+T Effector Memory Subset.
    PLoS One. 2015;10:e0142186.
    PubMed     Text format     Abstract available


  456. SAMUVEL DJ, Saxena N, Dhindsa JS, Singh AK, et al
    AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
    PLoS One. 2015;10:e0141781.
    PubMed     Text format     Abstract available


  457. MIYAKE S, Kim S, Suda W, Oshima K, et al
    Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.
    PLoS One. 2015;10:e0137429.
    PubMed     Text format     Abstract available


  458. MARIA Z, Campolo AR, Lacombe VA
    Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria.
    PLoS One. 2015;10:e0146033.
    PubMed     Text format     Abstract available


  459. KAVALIUNAS A, Wiberg M, Tinghog P, Glaser A, et al
    Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients.
    PLoS One. 2015;10:e0145435.
    PubMed     Text format     Abstract available


  460. REPPE S, Wang Y, Thompson WK, McEvoy LK, et al
    Genetic Sharing with Cardiovascular Disease Risk Factors and Diabetes Reveals Novel Bone Mineral Density Loci.
    PLoS One. 2015;10:e0144531.
    PubMed     Text format     Abstract available


  461. SANTOS CM, Lira-Junior R, Fischer RG, Santos AP, et al
    Systemic Antibiotics in Periodontal Treatment of Diabetic Patients: A Systematic Review.
    PLoS One. 2015;10:e0145262.
    PubMed     Text format     Abstract available


  462. WANG D, Shanina I, Toyofuku WM, Horwitz MS, et al
    Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy.
    PLoS One. 2015;10:e0145179.
    PubMed     Text format     Abstract available


  463. TSIVGOULIS G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, et al
    The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0144538.
    PubMed     Text format     Abstract available


  464. ALNEK K, Kisand K, Heilman K, Peet A, et al
    Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.
    PLoS One. 2015;10:e0142976.
    PubMed     Text format     Abstract available


  465. VARGA BE, Gao W, Laurik KL, Tatrai E, et al
    Investigating Tissue Optical Properties and Texture Descriptors of the Retina in Patients with Multiple Sclerosis.
    PLoS One. 2015;10:e0143711.
    PubMed     Text format     Abstract available


  466. TERASAKI M, Hiromura M, Mori Y, Kohashi K, et al
    Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.
    PLoS One. 2015;10:e0143396.
    PubMed     Text format     Abstract available


  467. MAKSHAKOV G, Nazarov V, Kochetova O, Surkova E, et al
    Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
    PLoS One. 2015;10:e0143375.
    PubMed     Text format     Abstract available


  468. FORNARI TA, Donate PB, Assis AF, Macedo C, et al
    Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.
    PLoS One. 2015;10:e0142688.
    PubMed     Text format     Abstract available


  469. ABOULENEIN-DJAMSHIDIAN F, Krssak M, Serbecic N, Rauschka H, et al
    CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?
    PLoS One. 2015;10:e0142272.
    PubMed     Text format     Abstract available


  470. RUGHOOPUTH MS, Zeng R, Yao Y
    Protein Diet Restriction Slows Chronic Kidney Disease Progression in Non-Diabetic and in Type 1 Diabetic Patients, but Not in Type 2 Diabetic Patients: A Meta-Analysis of Randomized Controlled Trials Using Glomerular Filtration Rate as a Surrogate.
    PLoS One. 2015;10:e0145505.
    PubMed     Text format     Abstract available


  471. SALHEEN SM, Panchapakesan U, Pollock CA, Woodman OL, et al
    The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose.
    PLoS One. 2015;10:e0143941.
    PubMed     Text format     Abstract available


    January 2014
  472. AHLGREN C, Oden A, Lycke J
    High nationwide incidence of multiple sclerosis in sweden.
    PLoS One. 2014;9:e108599.
    PubMed     Text format     Abstract available


  473. WENS I, Dalgas U, Vandenabeele F, Krekels M, et al
    Multiple sclerosis affects skeletal muscle characteristics.
    PLoS One. 2014;9:e108158.
    PubMed     Text format     Abstract available


  474. LASCAR N, Kennedy A, Hancock B, Jenkins D, et al
    Attitudes and Barriers to Exercise in Adults with Type 1 Diabetes (T1DM) and How Best to Address Them: A Qualitative Study.
    PLoS One. 2014;9:e108019.
    PubMed     Text format     Abstract available


  475. BOE LUNDE HM, Telstad W, Grytten N, Kyte L, et al
    Employment among Patients with Multiple Sclerosis-A Population Study.
    PLoS One. 2014;9:e103317.
    PubMed     Text format     Abstract available


  476. BESSHO M, Murase-Mishiba Y, Imagawa A, Terasaki J, et al
    Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel alpha-Cell Model of Insulin-Deficient Diabetes.
    PLoS One. 2014;9:e113254.
    PubMed     Text format     Abstract available


  477. BORREANI C, Bianchi E, Pietrolongo E, Rossi I, et al
    Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention.
    PLoS One. 2014;9:e109679.
    PubMed     Text format     Abstract available


  478. PINHAS-HAMIEL O, Hamiel U, Boyko V, Graph-Barel C, et al
    Trajectories of HbA1c Levels in Children and Youth with Type 1 Diabetes.
    PLoS One. 2014;9:e109109.
    PubMed     Text format     Abstract available


  479. KOEHRER P, Saab S, Berdeaux O, Isaico R, et al
    Erythrocyte phospholipid and polyunsaturated Fatty Acid composition in diabetic retinopathy.
    PLoS One. 2014;9:e106912.
    PubMed     Text format     Abstract available


  480. CAMINITI F, De Salvo S, De Cola MC, Russo M, et al
    Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
    PLoS One. 2014;9:e103151.
    PubMed     Text format     Abstract available


  481. KHSHEIBUN R, Paperna T, Volkowich A, Lejbkowicz I, et al
    Gene expression profiling of the response to interferon Beta in epstein-barr-transformed and primary B cells of patients with multiple sclerosis.
    PLoS One. 2014;9:e102331.
    PubMed     Text format     Abstract available


  482. PETERSON A, Hanberger L, Akesson K, Bojestig M, et al
    Improved results in paediatric diabetes care using a quality registry in an improvement collaborative: a case study in sweden.
    PLoS One. 2014;9:e97875.
    PubMed     Text format     Abstract available


  483. CRIMI A, Commowick O, Maarouf A, Ferre JC, et al
    Predictive Value of Imaging Markers at Multiple Sclerosis Disease Onset Based on Gadolinium- and USPIO-Enhanced MRI and Machine Learning.
    PLoS One. 2014;9:e93024.
    PubMed     Text format     Abstract available


  484. LLUFRIU S, Sepulveda M, Blanco Y, Marin P, et al
    Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis.
    PLoS One. 2014;9:e113936.
    PubMed     Text format     Abstract available


  485. LUNG TW, Hayes AJ, Herman WH, Si L, et al
    A Meta-Analysis of the Relative Risk of Mortality for Type 1 Diabetes Patients Compared to the General Population: Exploring Temporal Changes in Relative Mortality.
    PLoS One. 2014;9:e113635.
    PubMed     Text format     Abstract available


  486. MULS N, Dang HA, Sindic CJ, van Pesch V, et al
    Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients.
    PLoS One. 2014;9:e113025.
    PubMed     Text format     Abstract available


  487. GIANCHECCHI E, Crino A, Giorda E, Luciano R, et al
    Altered B Cell Homeostasis and Toll-Like Receptor 9-Driven Response in Type 1 Diabetes Carriers of the C1858T PTPN22 Allelic Variant: Implications in the Disease Pathogenesis.
    PLoS One. 2014;9:e110755.
    PubMed     Text format     Abstract available


  488. VAN BELLE TL, Vanherwegen AS, Feyaerts D, De Clercq P, et al
    1,25-Dihydroxyvitamin D3 and Its Analog TX527 Promote a Stable Regulatory T Cell Phenotype in T Cells from Type 1 Diabetes Patients.
    PLoS One. 2014;9:e109194.
    PubMed     Text format     Abstract available


  489. LIU Y, Gupta P, Lapointe M, Yotsapon T, et al
    Acylation stimulating protein, complement c3 and lipid metabolism in ketosis-prone diabetic subjects.
    PLoS One. 2014;9:e109237.
    PubMed     Text format     Abstract available


  490. MIYAZAKI Y, Li R, Rezk A, Misirliyan H, et al
    A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
    PLoS One. 2014;9:e105421.
    PubMed     Text format     Abstract available


  491. MANCINI M, Lanzillo R, Liuzzi R, Di Donato O, et al
    Internal jugular vein blood flow in multiple sclerosis patients and matched controls.
    PLoS One. 2014;9:e92730.
    PubMed     Text format     Abstract available


  492. SONG ZY, Yamasaki R, Kawano Y, Sato S, et al
    Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
    PLoS One. 2015;10:e0124923.
    PubMed     Text format     Abstract available


  493. MATAS E, Bau L, Martinez-Iniesta M, Romero-Pinel L, et al
    Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients.
    PLoS One. 2014;9:e112758.
    PubMed     Text format     Abstract available


  494. HADJIGEORGIOU G, Dardiotis E, Tsivgoulis G, Doskas T, et al
    Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA).
    PLoS One. 2014;9:e113933.
    PubMed     Text format     Abstract available


  495. ZIVADINOV R, Dwyer MG, Markovic-Plese S, Kennedy C, et al
    Effect of treatment with interferon Beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.
    PLoS One. 2014;9:e91098.
    PubMed     Text format     Abstract available


  496. MASSACESI L, Tramacere I, Amoroso S, Battaglia MA, et al
    Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial.
    PLoS One. 2014;9:e113371.
    PubMed     Text format     Abstract available


  497. ORTEGA-MADUENO I, Garcia-Montojo M, Dominguez-Mozo MI, Garcia-Martinez A, et al
    Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
    PLoS One. 2014;9:e104836.
    PubMed     Text format     Abstract available


  498. MARO JC, Fryback DG, Lieu TA, Lee GM, et al
    Responding to Vaccine Safety Signals during Pandemic Influenza: A Modeling Study.
    PLoS One. 2014;9:e115553.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: